Batch_ID,Filename,Pathway,Old_Pathway,MoA,Old_MoA,Compound,Samples_ID,Kept,Date,Run date,Duration,Duration_ID,Concentrations_Formatted,Concentrations_ID,Concentrations,Replicates,Replicates_ID,Comments
exp010821,exp010821.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-08-01,2021-08-18,0,0d,000 uM,000u,0,2,Temps01_000u_exp010821_run180821_01,NA
exp010821,exp010821.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-08-01,2021-08-18,0,0d,000 uM,000u,0,2,Temps02_000u_exp010821_run180821_02,NA
exp040821,exp040821.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-08-04,2021-08-18,0,0d,000 uM,000u,0,2,Temps01_000u_exp040821_run180821_23,NA
exp040821,exp040821.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-08-04,2021-08-18,0,0d,000 uM,000u,0,2,Temps02_000u_exp040821_run180821_24,NA
exp130921,exp130921.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-09-13,2021-09-29,0,0d,000 uM,000u,0,1,Temps01_000u_exp130921_run290921_48,NA
exp130921_in_vivo,exp130921.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-09-13,2021-11-10,0,0d,000 uM,000u,0,1,Temps02_000u_exp130921_run101121_19,"In vivo, tumoral samples"
exp200921_dose_response,exp200921.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-09-20,2021-11-10,0,0d,000 uM,000u,0,2,Temps01_000u_exp200921_run101121_01,NA
exp200921_dose_response,exp200921.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-09-20,2021-11-10,0,0d,000 uM,000u,0,2,Temps02_000u_exp200921_run101121_02,NA
exp181021,exp181021.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-10-18,2021-11-10,0,0d,000 uM,000u,0,2,Temps01_000u_exp181021_run101121_36,NA
exp181021,exp181021.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-10-18,2021-11-10,0,0d,000 uM,000u,0,2,Temps02_000u_exp181021_run101121_37,NA
exp151121,exp151121.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-11-15,2022-01-18,0,0d,000 uM,000u,0,2,Temps01_000u_exp151121_run180122_01,Low cluster density
exp151121,exp151121.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-11-15,2022-01-18,0,0d,000 uM,000u,0,2,Temps02_000u_exp151121_run180122_02,Low cluster density
exp271221,exp271221.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-12-27,2022-01-18,0,0d,000 uM,000u,0,2,Temps01_000u_exp271221_run180122_15,Low cluster density
exp271221,exp271221.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2021-12-27,2022-01-18,0,0d,000 uM,000u,0,2,Temps02_000u_exp271221_run180122_16,Low cluster density
exp070222,exp070222.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2022-02-07,2022-03-01,0,0d,000 uM,000u,0,2,Temps01_000u_exp070222_run010322_45,NA
exp070222,exp070222.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2022-02-07,2022-03-01,0,0d,000 uM,000u,0,2,Temps02_000u_exp070222_run010322_46,NA
exp220322,exp220322.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2022-03-22,2022-05-20,0,0d,000 uM,000u,0,2,Temps01_000u_exp220322_run200522_45,NA
exp220322,exp220322.tsv,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Control - time zero,Temps0,TRUE,2022-03-22,2022-05-20,0,0d,000 uM,000u,0,2,Temps02_000u_exp220322_run200522_46,NA
exp010821,exp010821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-01,2021-08-18,9,9d,000 uM,000u,0,4,Contro1_000u_exp010821_run180821_03,NA
exp010821,exp010821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-01,2021-08-18,9,9d,000 uM,000u,0,4,Contro2_000u_exp010821_run180821_04,NA
exp010821,exp010821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-01,2021-08-18,9,9d,000 uM,000u,0,4,Contro3_000u_exp010821_run180821_05,NA
exp010821,exp010821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-01,2021-08-18,9,9d,000 uM,000u,0,4,Contro4_000u_exp010821_run180821_06,NA
exp040821,exp040821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-04,2021-08-18,9,9d,000 uM,000u,0,4,Contro1_000u_exp040821_run180821_25,NA
exp040821,exp040821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-04,2021-08-18,9,9d,000 uM,000u,0,4,Contro2_000u_exp040821_run180821_26,NA
exp040821,exp040821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-04,2021-08-18,9,9d,000 uM,000u,0,4,Contro3_000u_exp040821_run180821_27,NA
exp040821,exp040821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-04,2021-08-18,9,9d,000 uM,000u,0,4,Contro4_000u_exp040821_run180821_28,NA
exp181021,exp181021.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-10-18,2021-11-10,9,9d,000 uM,000u,0,4,Contro1_000u_exp181021_run101121_38,NA
exp181021,exp181021.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-10-18,2021-11-10,9,9d,000 uM,000u,0,4,Contro2_000u_exp181021_run101121_39,NA
exp181021,exp181021.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-10-18,2021-11-10,9,9d,000 uM,000u,0,4,Contro3_000u_exp181021_run101121_40,NA
exp181021,exp181021.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-10-18,2021-11-10,9,9d,000 uM,000u,0,4,Contro4_000u_exp181021_run101121_41,NA
exp300821,exp300821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-30,2021-09-29,9,9d,000 uM,000u,0,4,Contro1_000u_exp300821_run290921_01,NA
exp300821,exp300821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-30,2021-09-29,9,9d,000 uM,000u,0,4,Contro2_000u_exp300821_run290921_02,NA
exp300821,exp300821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-30,2021-09-29,9,9d,000 uM,000u,0,4,Contro3_000u_exp300821_run290921_03,NA
exp300821,exp300821.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-08-30,2021-09-29,9,9d,000 uM,000u,0,4,Contro4_000u_exp300821_run290921_04,NA
exp130921,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-09-29,9,9d,000 uM,000u,0,4,Contro1_000u_exp130921_run290921_32,NA
exp130921,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-09-29,9,9d,000 uM,000u,0,4,Contro2_000u_exp130921_run290921_33,NA
exp130921,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-09-29,9,9d,000 uM,000u,0,4,Contro3_000u_exp130921_run290921_34,NA
exp130921,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-09-29,9,9d,000 uM,000u,0,4,Contro4_000u_exp130921_run290921_35,NA
exp200921,exp200921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-20,2021-10-11,9,9d,000 uM,000u,0,4,Contro1_000u_exp200921_run111021_09,Dose Response
exp200921,exp200921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-20,2021-10-11,9,9d,000 uM,000u,0,4,Contro2_000u_exp200921_run111021_10,Dose Response
exp200921,exp200921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-20,2021-10-11,9,9d,000 uM,000u,0,4,Contro3_000u_exp200921_run111021_11,Dose Response
exp200921,exp200921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-20,2021-10-11,9,9d,000 uM,000u,0,4,Contro4_000u_exp200921_run111021_12,Dose Response
exp151121,exp151121.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-11-15,2021-12-07,9,9d,000 uM,000u,0,4,Contro1_000u_exp151121_run071221_01,NA
exp151121,exp151121.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-11-15,2021-12-07,9,9d,000 uM,000u,0,4,Contro2_000u_exp151121_run071221_02,NA
exp151121,exp151121.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-11-15,2021-12-07,9,9d,000 uM,000u,0,4,Contro3_000u_exp151121_run071221_03,NA
exp151121,exp151121.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-11-15,2021-12-07,9,9d,000 uM,000u,0,4,Contro4_000u_exp151121_run071221_04,NA
exp271221,exp271221.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-12-27,2022-01-18,9,9d,000 uM,000u,0,4,Contro1_000u_exp271221_run180122_17,NA
exp271221,exp271221.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-12-27,2022-01-18,9,9d,000 uM,000u,0,4,Contro2_000u_exp271221_run180122_18,NA
exp271221,exp271221.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-12-27,2022-01-18,9,9d,000 uM,000u,0,4,Contro3_000u_exp271221_run180122_19,NA
exp271221,exp271221.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-12-27,2022-01-18,9,9d,000 uM,000u,0,4,Contro4_000u_exp271221_run180122_20,NA
exp070222,exp070222.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-02-07,2022-03-01,9,9d,000 uM,000u,0,4,Contro1_000u_exp070222_run010322_01,NA
exp070222,exp070222.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-02-07,2022-03-01,9,9d,000 uM,000u,0,4,Contro2_000u_exp070222_run010322_02,NA
exp070222,exp070222.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-02-07,2022-03-01,9,9d,000 uM,000u,0,4,Contro3_000u_exp070222_run010322_03,NA
exp070222,exp070222.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-02-07,2022-03-01,9,9d,000 uM,000u,0,4,Contro4_000u_exp070222_run010322_04,NA
exp220322,exp220322.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-03-22,2022-05-06,9,9d,000 uM,000u,0,4,Contro1_000u_exp220322_run060522_25,NA
exp220322,exp220322.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-03-22,2022-05-06,9,9d,000 uM,000u,0,4,Contro2_000u_exp220322_run060522_26,NA
exp220322,exp220322.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-03-22,2022-05-06,9,9d,000 uM,000u,0,4,Contro3_000u_exp220322_run060522_27,NA
exp220322,exp220322.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-03-22,2022-05-06,9,9d,000 uM,000u,0,4,Contro4_000u_exp220322_run060522_28,NA
exp130921_in_vivo,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-11-10,9,9d,000 uM,000u,0,8,Contro1_000u_exp130921_run101121_20,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-11-10,9,9d,000 uM,000u,0,8,Contro2_000u_exp130921_run101121_21,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-11-10,9,9d,000 uM,000u,0,8,Contro3_000u_exp130921_run101121_22,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-11-10,9,9d,000 uM,000u,0,8,Contro4_000u_exp130921_run101121_23,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-11-10,9,9d,000 uM,000u,0,8,Contro5_000u_exp130921_run101121_24,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-11-10,9,9d,000 uM,000u,0,8,Contro6_000u_exp130921_run101121_25,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-11-10,9,9d,000 uM,000u,0,8,Contro7_000u_exp130921_run101121_26,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2021-09-13,2021-11-10,9,9d,000 uM,000u,0,8,Contro8_000u_exp130921_run101121_27,"In vivo, tumoral samples"
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,4,Contro1_000u_exp281022_run141222_01,NA
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,4,Contro2_000u_exp281022_run141222_02,NA
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,4,Contro3_000u_exp281022_run141222_03,NA
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,4,Contro4_000u_exp281022_run141222_04,NA
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,Control - T75,CTRL,FALSE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,4,CTRL1_000u_exp281022_run141222_06,Control T 75 for `cetuximab`
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,Control - T75,CTRL,FALSE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,4,CTRL2_000u_exp281022_run141222_07,Control T 75 for `cetuximab`
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,Control - T75,CTRL,FALSE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,4,CTRL3_000u_exp281022_run141222_08,Control T 75 for `cetuximab`
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,Control - T75,CTRL,FALSE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,4,CTRL4_000u_exp281022_run141222_09,Control T 75 for `cetuximab`
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,P42,p42,TRUE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,1,p42_000u_exp281022_run141222_04,P42: evaluate drift
exp281022_t25,exp281022t25.tsv,Control,Control,Control,Control,P43,p43,TRUE,2022-10-28,2022-12-14,9,9d,000 uM,000u,0,1,p43_000u_exp281022_run141222_05,P43: evaluate drift
exp281022_time_course,exp281022gamme.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-10-28,2023-07-11,9,9d,000 uM,000u,0,4,9d_Contro1_000u_exp281022_run110723_01,Time Course
exp281022_time_course,exp281022gamme.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-10-28,2023-07-11,9,9d,000 uM,000u,0,4,9d_Contro2_000u_exp281022_run110723_02,Time Course
exp281022_time_course,exp281022gamme.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-10-28,2023-07-11,9,9d,000 uM,000u,0,4,9d_Contro3_000u_exp281022_run110723_03,Time Course
exp281022_time_course,exp281022gamme.tsv,Control,Control,Control,Control,Control,Contro,TRUE,2022-10-28,2023-07-11,9,9d,000 uM,000u,0,4,9d_Contro4_000u_exp281022_run110723_04,Time Course
exp130921_in_vivo,exp130921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-13,2021-11-10,9,9d,1 mg/kg,001m,0.001,8,Osimer1_001m_exp130921_run101121_28,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-13,2021-11-10,9,9d,1 mg/kg,001m,0.001,8,Osimer2_001m_exp130921_run101121_29,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-13,2021-11-10,9,9d,1 mg/kg,001m,0.001,8,Osimer3_001m_exp130921_run101121_30,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-13,2021-11-10,9,9d,1 mg/kg,001m,0.001,8,Osimer4_001m_exp130921_run101121_31,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-13,2021-11-10,9,9d,1 mg/kg,001m,0.001,8,Osimer5_001m_exp130921_run101121_32,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-13,2021-11-10,9,9d,1 mg/kg,001m,0.001,8,Osimer6_001m_exp130921_run101121_33,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-13,2021-11-10,9,9d,1 mg/kg,001m,0.001,8,Osimer7_001m_exp130921_run101121_34,"In vivo, tumoral samples"
exp130921_in_vivo,exp130921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-13,2021-11-10,9,9d,1 mg/kg,001m,0.001,8,Osimer8_001m_exp130921_run101121_35,"In vivo, tumoral samples"
exp010821,exp010821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-01,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer1_100n_exp010821_run180821_07,NA
exp010821,exp010821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-01,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer2_100n_exp010821_run180821_08,NA
exp010821,exp010821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-01,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer3_100n_exp010821_run180821_09,NA
exp010821,exp010821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-01,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer4_100n_exp010821_run180821_10,NA
exp040821,exp040821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-04,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer1_100n_exp040821_run180821_29,NA
exp040821,exp040821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-04,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer2_100n_exp040821_run180821_30,NA
exp040821,exp040821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-04,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer3_100n_exp040821_run180821_31,NA
exp040821,exp040821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-04,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer4_100n_exp040821_run180821_32,NA
exp300821,exp300821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-30,2021-09-29,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer1_100n_exp300821_run290921_05,NA
exp300821,exp300821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-30,2021-09-29,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer2_100n_exp300821_run290921_06,NA
exp300821,exp300821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-30,2021-09-29,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer3_100n_exp300821_run290921_07,NA
exp300821,exp300821.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-08-30,2021-09-29,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer4_100n_exp300821_run290921_08,NA
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,20 nM,020n,2e-8,4,Osimer1_020n_exp200921_run101121_03,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,20 nM,020n,2e-8,4,Osimer2_020n_exp200921_run101121_04,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,20 nM,020n,2e-8,4,Osimer3_020n_exp200921_run101121_05,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,20 nM,020n,2e-8,4,Osimer4_020n_exp200921_run101121_06,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer1_100n_exp200921_run101121_07,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer2_100n_exp200921_run101121_08,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer3_100n_exp200921_run101121_09,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,100 nM,100n,1.0000000000000001e-7,4,Osimer4_100n_exp200921_run101121_10,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,1 uM,001u,1e-6,4,Osimer1_001u_exp200921_run101121_11,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,1 uM,001u,1e-6,4,Osimer2_001u_exp200921_run101121_12,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,1 uM,001u,1e-6,4,Osimer3_001u_exp200921_run101121_13,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,1 uM,001u,1e-6,4,Osimer4_001u_exp200921_run101121_14,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,5 uM,005u,4.9999999999999996e-6,4,Osimer1_005u_exp200921_run101121_15,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,5 uM,005u,4.9999999999999996e-6,4,Osimer2_005u_exp200921_run101121_16,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,5 uM,005u,4.9999999999999996e-6,4,Osimer3_005u_exp200921_run101121_17,Dose Response
exp200921_dose_response,exp200921.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,Osimer,TRUE,2021-09-20,2021-11-10,9,9d,5 uM,005u,4.9999999999999996e-6,4,Osimer4_005u_exp200921_run101121_18,Dose Response
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-10-28,2023-07-11,9,9d,100 nM,100n,1.0000000000000001e-7,4,9d_osim1_100n_exp281022_run110723_01,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-10-28,2023-07-11,9,9d,100 nM,100n,1.0000000000000001e-7,4,9d_osim2_100n_exp281022_run110723_02,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-10-28,2023-07-11,9,9d,100 nM,100n,1.0000000000000001e-7,4,9d_osim3_100n_exp281022_run110723_03,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-10-28,2023-07-11,9,9d,100 nM,100n,1.0000000000000001e-7,4,9d_osim4_100n_exp281022_run110723_04,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-11-07,2023-07-11,19,19d,100 nM,100n,1.0000000000000001e-7,4,19d_osim1_100n_exp071122_run110723_09,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-11-07,2023-07-11,19,19d,100 nM,100n,1.0000000000000001e-7,4,19d_osim2_100n_exp071122_run110723_10,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-11-07,2023-07-11,19,19d,100 nM,100n,1.0000000000000001e-7,4,19d_osim3_100n_exp071122_run110723_11,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-11-07,2023-07-11,19,19d,100 nM,100n,1.0000000000000001e-7,4,19d_osim4_100n_exp071122_run110723_12,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-11-18,2023-07-11,30,30d,100 nM,100n,1.0000000000000001e-7,4,30d_osim1_100n_exp181122_run110723_17,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-11-18,2023-07-11,30,30d,100 nM,100n,1.0000000000000001e-7,4,30d_osim2_100n_exp181122_run110723_18,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-11-18,2023-07-11,30,30d,100 nM,100n,1.0000000000000001e-7,4,30d_osim3_100n_exp181122_run110723_19,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-11-18,2023-07-11,30,30d,100 nM,100n,1.0000000000000001e-7,4,30d_osim4_100n_exp181122_run110723_20,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-12-02,2023-07-11,45,1.5m,100 nM,100n,1.0000000000000001e-7,4,1.5m_osim1_100n_exp021222_run110723_25,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-12-02,2023-07-11,45,1.5m,100 nM,100n,1.0000000000000001e-7,4,1.5m_osim2_100n_exp021222_run110723_26,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-12-02,2023-07-11,45,1.5m,100 nM,100n,1.0000000000000001e-7,4,1.5m_osim3_100n_exp021222_run110723_27,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-12-02,2023-07-11,45,1.5m,100 nM,100n,1.0000000000000001e-7,4,1.5m_osim4_100n_exp021222_run110723_28,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-12-16,2023-07-11,60,2m,100 nM,100n,1.0000000000000001e-7,4,2m_osim1_100n_exp161222_run110723_33,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-12-16,2023-07-11,60,2m,100 nM,100n,1.0000000000000001e-7,4,2m_osim2_100n_exp161222_run110723_34,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-12-16,2023-07-11,60,2m,100 nM,100n,1.0000000000000001e-7,4,2m_osim3_100n_exp161222_run110723_35,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2022-12-16,2023-07-11,60,2m,100 nM,100n,1.0000000000000001e-7,4,2m_osim4_100n_exp161222_run110723_36,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2023-01-18,2023-07-11,90,3m,100 nM,100n,1.0000000000000001e-7,4,3m_osim1_100n_exp180123_run110723_41,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2023-01-18,2023-07-11,90,3m,100 nM,100n,1.0000000000000001e-7,4,3m_osim2_100n_exp180123_run110723_42,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2023-01-18,2023-07-11,90,3m,100 nM,100n,1.0000000000000001e-7,4,3m_osim3_100n_exp180123_run110723_43,Time Course
exp281022_time_course,exp281022gamme.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Osimertinb,osim,TRUE,2023-01-18,2023-07-11,90,3m,100 nM,100n,1.0000000000000001e-7,4,3m_osim4_100n_exp180123_run110723_44,Time Course
exp271221,exp271221.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,WZ4002,WZ4002,TRUE,2021-12-27,2022-01-14,9,9d,1 uM,001u,1e-6,4,WZ40021_001u_exp271221_run140122_01,Low cluster density
exp271221,exp271221.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,WZ4002,WZ4002,TRUE,2021-12-27,2022-01-14,9,9d,1 uM,001u,1e-6,4,WZ40022_001u_exp271221_run140122_02,Low cluster density
exp271221,exp271221.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,WZ4002,WZ4002,TRUE,2021-12-27,2022-01-14,9,9d,1 uM,001u,1e-6,4,WZ40023_001u_exp271221_run140122_03,Low cluster density
exp271221,exp271221.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,WZ4002,WZ4002,TRUE,2021-12-27,2022-01-14,9,9d,1 uM,001u,1e-6,4,WZ40024_001u_exp271221_run140122_04,Low cluster density
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Lazertinib,Lazert,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Lazert1_001u_exp070222_run010322_33,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Lazertinib,Lazert,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Lazert2_001u_exp070222_run010322_34,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Lazertinib,Lazert,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Lazert3_001u_exp070222_run010322_35,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Lazertinib,Lazert,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Lazert4_001u_exp070222_run010322_36,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Rociletinib,Rocile,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Rocile1_001u_exp070222_run010322_37,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Rociletinib,Rocile,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Rocile2_001u_exp070222_run010322_38,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Rociletinib,Rocile,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Rocile3_001u_exp070222_run010322_39,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Rociletinib,Rocile,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Rocile4_001u_exp070222_run010322_40,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Mavelertinib,Mavele,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Mavele1_001u_exp070222_run010322_41,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Mavelertinib,Mavele,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Mavele2_001u_exp070222_run010322_42,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Mavelertinib,Mavele,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Mavele3_001u_exp070222_run010322_43,NA
exp070222,exp070222.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Mavelertinib,Mavele,TRUE,2022-02-07,2022-03-01,9,9d,1 µM,001u,1e-6,4,Mavele4_001u_exp070222_run010322_44,NA
exp281022_t25,exp281022t25.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Cetuximab,Cetux,FALSE,2022-10-28,2022-12-14,9,9d,20 uM,020u,1.9999999999999998e-5,4,Cetux1_020u_exp281022_run141222_14,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp281022_t25,exp281022t25.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Cetuximab,Cetux,FALSE,2022-10-28,2022-12-14,9,9d,20 uM,020u,1.9999999999999998e-5,4,Cetux2_020u_exp281022_run141222_15,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp281022_t25,exp281022t25.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Cetuximab,Cetux,FALSE,2022-10-28,2022-12-14,9,9d,20 uM,020u,1.9999999999999998e-5,4,Cetux3_020u_exp281022_run141222_16,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp281022_t25,exp281022t25.tsv,RTK,EGFR,EGFR inhibitor (3rd gen.),3rd generation EGFR-TKIs,Cetuximab,Cetux,FALSE,2022-10-28,2022-12-14,9,9d,20 uM,020u,1.9999999999999998e-5,4,Cetux4_020u_exp281022_run141222_17,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp300821,exp300821.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gefiti,TRUE,2021-08-30,2021-09-29,9,9d,2 uM,002u,2e-6,4,Gefiti1_002u_exp300821_run290921_13,NA
exp300821,exp300821.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gefiti,TRUE,2021-08-30,2021-09-29,9,9d,2 uM,002u,2e-6,4,Gefiti2_002u_exp300821_run290921_14,NA
exp300821,exp300821.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gefiti,TRUE,2021-08-30,2021-09-29,9,9d,2 uM,002u,2e-6,4,Gefiti3_002u_exp300821_run290921_15,NA
exp300821,exp300821.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gefiti,TRUE,2021-08-30,2021-09-29,9,9d,2 uM,002u,2e-6,4,Gefiti4_002u_exp300821_run290921_16,NA
exp151121,exp151121.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gefiti,TRUE,2021-11-15,2021-12-07,9,9d,2 uM,002u,2e-6,4,Gefiti1_002u_exp151121_run071221_13,NA
exp151121,exp151121.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gefiti,TRUE,2021-11-15,2021-12-07,9,9d,2 uM,002u,2e-6,4,Gefiti2_002u_exp151121_run071221_14,NA
exp151121,exp151121.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gefiti,TRUE,2021-11-15,2021-12-07,9,9d,2 uM,002u,2e-6,4,Gefiti3_002u_exp151121_run071221_15,NA
exp151121,exp151121.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gefiti,TRUE,2021-11-15,2021-12-07,9,9d,2 uM,002u,2e-6,4,Gefiti4_002u_exp151121_run071221_16,NA
exp281022_t25,exp281022t25.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gef,FALSE,2022-10-28,2022-12-14,9,9d,2 uM,002u,2e-6,4,Gef1_002u_exp281022_run141222_18,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp281022_t25,exp281022t25.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gef,FALSE,2022-10-28,2022-12-14,9,9d,2 uM,002u,2e-6,4,Gef2_002u_exp281022_run141222_19,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp281022_t25,exp281022t25.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gef,FALSE,2022-10-28,2022-12-14,9,9d,2 uM,002u,2e-6,4,Gef3_002u_exp281022_run141222_20,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp281022_t25,exp281022t25.tsv,RTK,EGFR,EGFR inhibitor (1st gen.),1st generation EGFR-TKIs,Gefitinib,Gef,FALSE,2022-10-28,2022-12-14,9,9d,2 uM,002u,2e-6,4,Gef4_002u_exp281022_run141222_21,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp151121,exp151121.tsv,RTK,EGFR,PROTAC conjugated EGFR inhibitor,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,TRUE,2021-11-15,2021-12-07,9,9d,10 uM,010u,9.999999999999999e-6,4,PROTAC1_010u_exp151121_run071221_17,NA
exp151121,exp151121.tsv,RTK,EGFR,PROTAC conjugated EGFR inhibitor,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,TRUE,2021-11-15,2021-12-07,9,9d,10 uM,010u,9.999999999999999e-6,4,PROTAC2_010u_exp151121_run071221_18,NA
exp151121,exp151121.tsv,RTK,EGFR,PROTAC conjugated EGFR inhibitor,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,TRUE,2021-11-15,2021-12-07,9,9d,10 uM,010u,9.999999999999999e-6,4,PROTAC3_010u_exp151121_run071221_19,NA
exp151121,exp151121.tsv,RTK,EGFR,PROTAC conjugated EGFR inhibitor,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,TRUE,2021-11-15,2021-12-07,9,9d,10 uM,010u,9.999999999999999e-6,4,PROTAC4_010u_exp151121_run071221_20,NA
exp281022_t25,exp281022t25.tsv,RTK,EGFR,PROTAC conjugated EGFR inhibitor,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,FALSE,2022-10-28,2022-12-14,9,9d,10 uM,010u,9.999999999999999e-6,4,PROTAC1_010u_exp281022_run141222_10,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp281022_t25,exp281022t25.tsv,RTK,EGFR,PROTAC conjugated EGFR inhibitor,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,FALSE,2022-10-28,2022-12-14,9,9d,10 uM,010u,9.999999999999999e-6,4,PROTAC2_010u_exp281022_run141222_11,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp281022_t25,exp281022t25.tsv,RTK,EGFR,PROTAC conjugated EGFR inhibitor,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,FALSE,2022-10-28,2022-12-14,9,9d,10 uM,010u,9.999999999999999e-6,4,PROTAC3_010u_exp281022_run141222_12,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp281022_t25,exp281022t25.tsv,RTK,EGFR,PROTAC conjugated EGFR inhibitor,PROTAC conjugated,Gefitinib-PROTAC-1,PROTAC,FALSE,2022-10-28,2022-12-14,9,9d,10 uM,010u,9.999999999999999e-6,4,PROTAC4_010u_exp281022_run141222_13,"T 75 for `cetuximab`, Not enough concentration of the anti-EGFR antibody, cetuximab"
exp271221,exp271221.tsv,RAS-MAPK,KRAS,KRAS inhibitor,PROTAC conjugated,Sotorasib (AMG-510),Sotora,TRUE,2021-12-27,2022-01-14,9,9d,35 uM,035u,3.5e-5,4,Sotora1_035u_exp271221_run140122_05,Low cluster density
exp271221,exp271221.tsv,RAS-MAPK,KRAS,KRAS inhibitor,PROTAC conjugated,Sotorasib (AMG-510),Sotora,TRUE,2021-12-27,2022-01-14,9,9d,35 uM,035u,3.5e-5,4,Sotora2_035u_exp271221_run140122_06,Low cluster density
exp271221,exp271221.tsv,RAS-MAPK,KRAS,KRAS inhibitor,PROTAC conjugated,Sotorasib (AMG-510),Sotora,TRUE,2021-12-27,2022-01-14,9,9d,35 uM,035u,3.5e-5,4,Sotora3_035u_exp271221_run140122_07,Low cluster density
exp271221,exp271221.tsv,RAS-MAPK,KRAS,KRAS inhibitor,PROTAC conjugated,Sotorasib (AMG-510),Sotora,TRUE,2021-12-27,2022-01-14,9,9d,35 uM,035u,3.5e-5,4,Sotora4_035u_exp271221_run140122_08,Low cluster density
exp300821,exp300821.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,CCT196969,CCT196,TRUE,2021-08-30,2021-09-29,9,9d,1 uM,001u,1e-6,4,CCT1961_001u_exp300821_run290921_25,NA
exp300821,exp300821.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,CCT196969,CCT196,TRUE,2021-08-30,2021-09-29,9,9d,1 uM,001u,1e-6,4,CCT1962_001u_exp300821_run290921_26,NA
exp300821,exp300821.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,CCT196969,CCT196,TRUE,2021-08-30,2021-09-29,9,9d,1 uM,001u,1e-6,4,CCT1963_001u_exp300821_run290921_27,NA
exp300821,exp300821.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,CCT196969,CCT196,TRUE,2021-08-30,2021-09-29,9,9d,1 uM,001u,1e-6,4,CCT1964_001u_exp300821_run290921_28,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,CCT196969,CCT196,TRUE,2021-11-15,2021-12-07,9,9d,1 uM,001u,1e-6,4,CCT1961_001u_exp151121_run071221_25,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,CCT196969,CCT196,TRUE,2021-11-15,2021-12-07,9,9d,1 uM,001u,1e-6,4,CCT1962_001u_exp151121_run071221_26,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,CCT196969,CCT196,TRUE,2021-11-15,2021-12-07,9,9d,1 uM,001u,1e-6,4,CCT1963_001u_exp151121_run071221_27,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,CCT196969,CCT196,TRUE,2021-11-15,2021-12-07,9,9d,1 uM,001u,1e-6,4,CCT1964_001u_exp151121_run071221_28,NA
exp130921,exp130921.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,LY3009120,LY3009,TRUE,2021-09-13,2021-09-29,9,9d,3 uM,003u,3e-6,4,LY30091_003u_exp130921_run290921_36,NA
exp130921,exp130921.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,LY3009120,LY3009,TRUE,2021-09-13,2021-09-29,9,9d,3 uM,003u,3e-6,4,LY30092_003u_exp130921_run290921_37,NA
exp130921,exp130921.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,LY3009120,LY3009,TRUE,2021-09-13,2021-09-29,9,9d,3 uM,003u,3e-6,4,LY30093_003u_exp130921_run290921_38,NA
exp130921,exp130921.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,LY3009120,LY3009,TRUE,2021-09-13,2021-09-29,9,9d,3 uM,003u,3e-6,4,LY30094_003u_exp130921_run290921_39,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,LY3009120,LY3009,TRUE,2021-11-15,2021-12-07,9,9d,3 uM,003u,3e-6,4,LY30091_003u_exp151121_run071221_29,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,LY3009120,LY3009,TRUE,2021-11-15,2021-12-07,9,9d,3 uM,003u,3e-6,4,LY30092_003u_exp151121_run071221_30,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,LY3009120,LY3009,TRUE,2021-11-15,2021-12-07,9,9d,3 uM,003u,3e-6,4,LY30093_003u_exp151121_run071221_31,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,LY3009120,LY3009,TRUE,2021-11-15,2021-12-07,9,9d,3 uM,003u,3e-6,4,LY30094_003u_exp151121_run071221_32,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,RAF265,RAF265,TRUE,2021-11-15,2021-12-07,9,9d,5 uM,005u,4.9999999999999996e-6,4,RAF2651_005u_exp151121_run071221_21,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,RAF265,RAF265,TRUE,2021-11-15,2021-12-07,9,9d,5 uM,005u,4.9999999999999996e-6,4,RAF2652_005u_exp151121_run071221_22,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,RAF265,RAF265,TRUE,2021-11-15,2021-12-07,9,9d,5 uM,005u,4.9999999999999996e-6,4,RAF2653_005u_exp151121_run071221_23,NA
exp151121,exp151121.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,RAF265,RAF265,TRUE,2021-11-15,2021-12-07,9,9d,5 uM,005u,4.9999999999999996e-6,4,RAF2654_005u_exp151121_run071221_24,NA
exp070222,exp070222.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,Vemurafenib,Vemura,TRUE,2022-02-07,2022-05-06,9,9d,7 uM,007u,7e-6,4,Vemura1_007u_exp070222_run060522_01,NA
exp070222,exp070222.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,Vemurafenib,Vemura,TRUE,2022-02-07,2022-05-06,9,9d,7 uM,007u,7e-6,4,Vemura2_007u_exp070222_run060522_02,NA
exp070222,exp070222.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,Vemurafenib,Vemura,TRUE,2022-02-07,2022-05-06,9,9d,7 uM,007u,7e-6,4,Vemura3_007u_exp070222_run060522_03,NA
exp070222,exp070222.tsv,RAS-MAPK,RAF,RAF  inhibitor,PROTAC conjugated,Vemurafenib,Vemura,TRUE,2022-02-07,2022-05-06,9,9d,7 uM,007u,7e-6,4,Vemura4_007u_exp070222_run060522_04,NA
exp010821,exp010821.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-08-01,2021-08-18,9,9d,30 nM,030n,3.0000000000000004e-8,4,Tramet1_030n_exp010821_run180821_11,NA
exp010821,exp010821.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-08-01,2021-08-18,9,9d,30 nM,030n,3.0000000000000004e-8,4,Tramet2_030n_exp010821_run180821_12,NA
exp010821,exp010821.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-08-01,2021-08-18,9,9d,30 nM,030n,3.0000000000000004e-8,4,Tramet3_030n_exp010821_run180821_13,NA
exp010821,exp010821.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-08-01,2021-08-18,9,9d,30 nM,030n,3.0000000000000004e-8,4,Tramet4_030n_exp010821_run180821_14,NA
exp040821,exp040821.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-08-04,2021-08-18,9,9d,30 nM,030n,3.0000000000000004e-8,4,Tramet1_030n_exp040821_run180821_33,NA
exp040821,exp040821.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-08-04,2021-08-18,9,9d,30 nM,030n,3.0000000000000004e-8,4,Tramet2_030n_exp040821_run180821_34,NA
exp040821,exp040821.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-08-04,2021-08-18,9,9d,30 nM,030n,3.0000000000000004e-8,4,Tramet3_030n_exp040821_run180821_35,NA
exp040821,exp040821.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-08-04,2021-08-18,9,9d,30 nM,030n,3.0000000000000004e-8,4,Tramet4_030n_exp040821_run180821_36,NA
exp151121,exp151121.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-11-15,2021-12-07,9,9d,40 nM,040n,4e-8,4,Tramet1_040n_exp151121_run071221_05,NA
exp151121,exp151121.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-11-15,2021-12-07,9,9d,40 nM,040n,4e-8,4,Tramet2_040n_exp151121_run071221_06,NA
exp151121,exp151121.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-11-15,2021-12-07,9,9d,40 nM,040n,4e-8,4,Tramet3_040n_exp151121_run071221_07,NA
exp151121,exp151121.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,Trametinib,Tramet,TRUE,2021-11-15,2021-12-07,9,9d,40 nM,040n,4e-8,4,Tramet4_040n_exp151121_run071221_08,NA
exp151121,exp151121.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,U0126-EtOH,U0126E,TRUE,2021-11-15,2021-12-07,9,9d,30 uM,030u,2.9999999999999997e-5,4,U0126E1_030u_exp151121_run071221_09,NA
exp151121,exp151121.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,U0126-EtOH,U0126E,TRUE,2021-11-15,2021-12-07,9,9d,30 uM,030u,2.9999999999999997e-5,4,U0126E2_030u_exp151121_run071221_10,NA
exp151121,exp151121.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,U0126-EtOH,U0126E,TRUE,2021-11-15,2021-12-07,9,9d,30 uM,030u,2.9999999999999997e-5,4,U0126E3_030u_exp151121_run071221_11,NA
exp151121,exp151121.tsv,RAS-MAPK,MEK,MEK inhibitor,PROTAC conjugated,U0126-EtOH,U0126E,TRUE,2021-11-15,2021-12-07,9,9d,30 uM,030u,2.9999999999999997e-5,4,U0126E4_030u_exp151121_run071221_12,NA
exp271221,exp271221.tsv,RTK,ALK,"ALK, MET inhibitor",ALK and c-Met,Crizotinib,Crizot,TRUE,2021-12-27,2022-01-14,9,9d,2 uM,002u,2e-6,4,Crizot1_002u_exp271221_run140122_13,Low cluster density
exp271221,exp271221.tsv,RTK,ALK,"ALK, MET inhibitor",ALK and c-Met,Crizotinib,Crizot,TRUE,2021-12-27,2022-01-14,9,9d,2 uM,002u,2e-6,4,Crizot2_002u_exp271221_run140122_14,Low cluster density
exp271221,exp271221.tsv,RTK,ALK,"ALK, MET inhibitor",ALK and c-Met,Crizotinib,Crizot,TRUE,2021-12-27,2022-01-14,9,9d,2 uM,002u,2e-6,4,Crizot3_002u_exp271221_run140122_15,Low cluster density
exp271221,exp271221.tsv,RTK,ALK,"ALK, MET inhibitor",ALK and c-Met,Crizotinib,Crizot,TRUE,2021-12-27,2022-01-14,9,9d,2 uM,002u,2e-6,4,Crizot4_002u_exp271221_run140122_16,Low cluster density
exp271221,exp271221.tsv,RTK,ALK,ALK inhibitor,ALK,TAE684 (NVP-TAE684),TAE684,TRUE,2021-12-27,2022-01-14,9,9d,1 uM,001u,1e-6,4,TAE6841_001u_exp271221_run140122_17,Low cluster density
exp271221,exp271221.tsv,RTK,ALK,ALK inhibitor,ALK,TAE684 (NVP-TAE684),TAE684,TRUE,2021-12-27,2022-01-14,9,9d,1 uM,001u,1e-6,4,TAE6842_001u_exp271221_run140122_18,Low cluster density
exp271221,exp271221.tsv,RTK,ALK,ALK inhibitor,ALK,TAE684 (NVP-TAE684),TAE684,TRUE,2021-12-27,2022-01-14,9,9d,1 uM,001u,1e-6,4,TAE6843_001u_exp271221_run140122_19,Low cluster density
exp271221,exp271221.tsv,RTK,ALK,ALK inhibitor,ALK,TAE684 (NVP-TAE684),TAE684,TRUE,2021-12-27,2022-01-14,9,9d,1 uM,001u,1e-6,4,TAE6844_001u_exp271221_run140122_20,Low cluster density
exp271221,exp271221.tsv,RTK,FGFR,FGFR inhibitor,ALK,Infigratinib (BGJ398),BGJ398,TRUE,2021-12-27,2022-01-14,9,9d,7 uM,007u,7e-6,4,BGJ3981_007u_exp271221_run140122_09,Low cluster density
exp271221,exp271221.tsv,RTK,FGFR,FGFR inhibitor,ALK,Infigratinib (BGJ398),BGJ398,TRUE,2021-12-27,2022-01-14,9,9d,7 uM,007u,7e-6,4,BGJ3982_007u_exp271221_run140122_10,Low cluster density
exp271221,exp271221.tsv,RTK,FGFR,FGFR inhibitor,ALK,Infigratinib (BGJ398),BGJ398,TRUE,2021-12-27,2022-01-14,9,9d,7 uM,007u,7e-6,4,BGJ3983_007u_exp271221_run140122_11,Low cluster density
exp271221,exp271221.tsv,RTK,FGFR,FGFR inhibitor,ALK,Infigratinib (BGJ398),BGJ398,TRUE,2021-12-27,2022-01-14,9,9d,7 uM,007u,7e-6,4,BGJ3984_007u_exp271221_run140122_12,Low cluster density
exp010821,exp010821.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-08-01,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Pemetr1_100n_exp010821_run180821_15,NA
exp010821,exp010821.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-08-01,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Pemetr2_100n_exp010821_run180821_16,NA
exp010821,exp010821.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-08-01,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Pemetr3_100n_exp010821_run180821_17,NA
exp010821,exp010821.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-08-01,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Pemetr4_100n_exp010821_run180821_18,NA
exp040821,exp040821.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-08-04,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Pemetr1_100n_exp040821_run180821_37,NA
exp040821,exp040821.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-08-04,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Pemetr2_100n_exp040821_run180821_38,NA
exp040821,exp040821.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-08-04,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Pemetr3_100n_exp040821_run180821_39,NA
exp040821,exp040821.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-08-04,2021-08-18,9,9d,100 nM,100n,1.0000000000000001e-7,4,Pemetr4_100n_exp040821_run180821_40,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-10-18,2021-11-25,9,9d,80 nM,080n,8e-8,4,Pemetr1_080n_exp181021_run251121_01,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-10-18,2021-11-25,9,9d,80 nM,080n,8e-8,4,Pemetr2_080n_exp181021_run251121_02,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-10-18,2021-11-25,9,9d,80 nM,080n,8e-8,4,Pemetr3_080n_exp181021_run251121_03,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,Pemetr,TRUE,2021-10-18,2021-11-25,9,9d,80 nM,080n,8e-8,4,Pemetr4_080n_exp181021_run251121_04,NA
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-10-28,2023-07-11,9,9d,100 nM,100n,1.0000000000000001e-7,4,9d_PEM1_100n_exp281022_run110723_05,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-10-28,2023-07-11,9,9d,100 nM,100n,1.0000000000000001e-7,4,9d_PEM2_100n_exp281022_run110723_06,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-10-28,2023-07-11,9,9d,100 nM,100n,1.0000000000000001e-7,4,9d_PEM3_100n_exp281022_run110723_07,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-10-28,2023-07-11,9,9d,100 nM,100n,1.0000000000000001e-7,4,9d_PEM4_100n_exp281022_run110723_08,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-11-07,2023-07-11,19,19d,100 nM,100n,1.0000000000000001e-7,4,19d_PEM1_100n_exp071122_run110723_13,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-11-07,2023-07-11,19,19d,100 nM,100n,1.0000000000000001e-7,4,19d_PEM2_100n_exp071122_run110723_14,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-11-07,2023-07-11,19,19d,100 nM,100n,1.0000000000000001e-7,4,19d_PEM3_100n_exp071122_run110723_15,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-11-07,2023-07-11,19,19d,100 nM,100n,1.0000000000000001e-7,4,19d_PEM4_100n_exp071122_run110723_16,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-11-18,2023-07-11,30,30d,100 nM,100n,1.0000000000000001e-7,4,30d_PEM1_100n_exp181122_run110723_21,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-11-18,2023-07-11,30,30d,100 nM,100n,1.0000000000000001e-7,4,30d_PEM2_100n_exp181122_run110723_22,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-11-18,2023-07-11,30,30d,100 nM,100n,1.0000000000000001e-7,4,30d_PEM3_100n_exp181122_run110723_23,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-11-18,2023-07-11,30,30d,100 nM,100n,1.0000000000000001e-7,4,30d_PEM4_100n_exp181122_run110723_24,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-12-02,2023-07-11,45,1.5m,100 nM,100n,1.0000000000000001e-7,4,1.5m_PEM1_100n_exp021222_run110723_29,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-12-02,2023-07-11,45,1.5m,100 nM,100n,1.0000000000000001e-7,4,1.5m_PEM2_100n_exp021222_run110723_30,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-12-02,2023-07-11,45,1.5m,100 nM,100n,1.0000000000000001e-7,4,1.5m_PEM3_100n_exp021222_run110723_31,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-12-02,2023-07-11,45,1.5m,100 nM,100n,1.0000000000000001e-7,4,1.5m_PEM4_100n_exp021222_run110723_32,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-12-16,2023-07-11,60,2m,100 nM,100n,1.0000000000000001e-7,4,2m_PEM1_100n_exp161222_run110723_37,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-12-16,2023-07-11,60,2m,100 nM,100n,1.0000000000000001e-7,4,2m_PEM2_100n_exp161222_run110723_38,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-12-16,2023-07-11,60,2m,100 nM,100n,1.0000000000000001e-7,4,2m_PEM3_100n_exp161222_run110723_39,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2022-12-16,2023-07-11,60,2m,100 nM,100n,1.0000000000000001e-7,4,2m_PEM4_100n_exp161222_run110723_40,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2023-01-18,2023-07-11,90,3m,100 nM,100n,1.0000000000000001e-7,4,3m_PEM1_100n_exp180123_run110723_45,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2023-01-18,2023-07-11,90,3m,100 nM,100n,1.0000000000000001e-7,4,3m_PEM2_100n_exp180123_run110723_46,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2023-01-18,2023-07-11,90,3m,100 nM,100n,1.0000000000000001e-7,4,3m_PEM3_100n_exp180123_run110723_47,Time Course
exp281022_time_course,exp281022gamme.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pemetrexed,PEM,TRUE,2023-01-18,2023-07-11,90,3m,100 nM,100n,1.0000000000000001e-7,4,3m_PEM4_100n_exp180123_run110723_48,Time Course
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Methotrexate,Methot,TRUE,2022-03-22,2022-05-06,9,9d,40 nM,040n,4e-8,4,Methot1_040n_exp220322_run060522_33,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Methotrexate,Methot,TRUE,2022-03-22,2022-05-06,9,9d,40 nM,040n,4e-8,4,Methot2_040n_exp220322_run060522_34,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Methotrexate,Methot,TRUE,2022-03-22,2022-05-06,9,9d,40 nM,040n,4e-8,4,Methot3_040n_exp220322_run060522_35,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Methotrexate,Methot,TRUE,2022-03-22,2022-05-06,9,9d,40 nM,040n,4e-8,4,Methot4_040n_exp220322_run060522_36,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pralatrexate,Pralat,TRUE,2022-03-22,2022-05-06,9,9d,3 nM,003n,3.0000000000000004e-9,4,Pralat1_003n_exp220322_run060522_29,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pralatrexate,Pralat,TRUE,2022-03-22,2022-05-06,9,9d,3 nM,003n,3.0000000000000004e-9,4,Pralat2_003n_exp220322_run060522_30,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pralatrexate,Pralat,TRUE,2022-03-22,2022-05-06,9,9d,3 nM,003n,3.0000000000000004e-9,4,Pralat3_003n_exp220322_run060522_31,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,Antifolate,antifolate,Pralatrexate,Pralat,TRUE,2022-03-22,2022-05-06,9,9d,3 nM,003n,3.0000000000000004e-9,4,Pralat4_003n_exp220322_run060522_32,NA
exp300821,exp300821.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Cisplatin,Cispla,TRUE,2021-08-30,2021-09-29,9,9d,250 nM,250n,2.5000000000000004e-7,4,Cispla1_250n_exp300821_run290921_17,NA
exp300821,exp300821.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Cisplatin,Cispla,TRUE,2021-08-30,2021-09-29,9,9d,250 nM,250n,2.5000000000000004e-7,4,Cispla2_250n_exp300821_run290921_18,NA
exp300821,exp300821.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Cisplatin,Cispla,TRUE,2021-08-30,2021-09-29,9,9d,250 nM,250n,2.5000000000000004e-7,4,Cispla3_250n_exp300821_run290921_19,NA
exp300821,exp300821.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Cisplatin,Cispla,TRUE,2021-08-30,2021-09-29,9,9d,250 nM,250n,2.5000000000000004e-7,4,Cispla4_250n_exp300821_run290921_20,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Cisplatin,Cispla,TRUE,2021-10-18,2021-11-25,9,9d,500 nM,500n,5.000000000000001e-7,4,Cispla1_500n_exp181021_run251121_09,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Cisplatin,Cispla,TRUE,2021-10-18,2021-11-25,9,9d,500 nM,500n,5.000000000000001e-7,4,Cispla2_500n_exp181021_run251121_10,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Cisplatin,Cispla,TRUE,2021-10-18,2021-11-25,9,9d,500 nM,500n,5.000000000000001e-7,4,Cispla3_500n_exp181021_run251121_11,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Cisplatin,Cispla,TRUE,2021-10-18,2021-11-25,9,9d,500 nM,500n,5.000000000000001e-7,4,Cispla4_500n_exp181021_run251121_12,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Oxaliplatin,Oxalip,TRUE,2022-02-07,2022-05-06,9,9d,5 uM,005u,4.9999999999999996e-6,4,Oxalip1_005u_exp070222_run060522_09,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Oxaliplatin,Oxalip,TRUE,2022-02-07,2022-05-06,9,9d,5 uM,005u,4.9999999999999996e-6,4,Oxalip2_005u_exp070222_run060522_10,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Oxaliplatin,Oxalip,TRUE,2022-02-07,2022-05-06,9,9d,5 uM,005u,4.9999999999999996e-6,4,Oxalip3_005u_exp070222_run060522_11,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Oxaliplatin,Oxalip,TRUE,2022-02-07,2022-05-06,9,9d,5 uM,005u,4.9999999999999996e-6,4,Oxalip4_005u_exp070222_run060522_12,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Carboplatin,Carbop,TRUE,2022-02-07,2022-05-06,9,9d,7 uM,007u,7e-6,4,Carbop1_007u_exp070222_run060522_13,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Carboplatin,Carbop,TRUE,2022-02-07,2022-05-06,9,9d,7 uM,007u,7e-6,4,Carbop2_007u_exp070222_run060522_14,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Carboplatin,Carbop,TRUE,2022-02-07,2022-05-06,9,9d,7 uM,007u,7e-6,4,Carbop3_007u_exp070222_run060522_15,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Alkylating agent,platinum,Carboplatin,Carbop,TRUE,2022-02-07,2022-05-06,9,9d,7 uM,007u,7e-6,4,Carbop4_007u_exp070222_run060522_16,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Anthracycline - topoisomerase inhibitor,topoisomerase inhibitor,Doxorubicin,Doxoru,TRUE,2021-10-18,2021-11-25,9,9d,80 nM,080n,8e-8,4,Doxoru1_080n_exp181021_run251121_05,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Anthracycline - topoisomerase inhibitor,topoisomerase inhibitor,Doxorubicin,Doxoru,TRUE,2021-10-18,2021-11-25,9,9d,80 nM,080n,8e-8,4,Doxoru2_080n_exp181021_run251121_06,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Anthracycline - topoisomerase inhibitor,topoisomerase inhibitor,Doxorubicin,Doxoru,TRUE,2021-10-18,2021-11-25,9,9d,80 nM,080n,8e-8,4,Doxoru3_080n_exp181021_run251121_07,NA
exp181021,exp181021.tsv,Chemotherapy,Chemotherapy,Anthracycline - topoisomerase inhibitor,topoisomerase inhibitor,Doxorubicin,Doxoru,TRUE,2021-10-18,2021-11-25,9,9d,80 nM,080n,8e-8,4,Doxoru4_080n_exp181021_run251121_08,NA
exp151121,exp151121.tsv,Chemotherapy,Chemotherapy,Alkylating agent,alkylating agent,Mitomycin C,Mitomy,TRUE,2021-11-15,2021-12-07,9,9d,"0,02 µg/ml",0.02u,2e-8,4,Mitomy1_0.02u_exp151121_run071221_37,NA
exp151121,exp151121.tsv,Chemotherapy,Chemotherapy,Alkylating agent,alkylating agent,Mitomycin C,Mitomy,TRUE,2021-11-15,2021-12-07,9,9d,"0,02 µg/ml",0.02u,2e-8,4,Mitomy2_0.02u_exp151121_run071221_38,NA
exp151121,exp151121.tsv,Chemotherapy,Chemotherapy,Alkylating agent,alkylating agent,Mitomycin C,Mitomy,TRUE,2021-11-15,2021-12-07,9,9d,"0,02 µg/ml",0.02u,2e-8,4,Mitomy3_0.02u_exp151121_run071221_39,NA
exp151121,exp151121.tsv,Chemotherapy,Chemotherapy,Alkylating agent,alkylating agent,Mitomycin C,Mitomy,TRUE,2021-11-15,2021-12-07,9,9d,"0,02 µg/ml",0.02u,2e-8,4,Mitomy4_0.02u_exp151121_run071221_40,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Anti metabolite (thymidylate synthase inhibitor),Pyrimidine antagonist,5-Fluorouracil,5Fluor,TRUE,2022-02-07,2022-05-06,9,9d,6 uM,006u,6e-6,4,5Fluor1_006u_exp070222_run060522_05,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Anti metabolite (thymidylate synthase inhibitor),Pyrimidine antagonist,5-Fluorouracil,5Fluor,TRUE,2022-02-07,2022-05-06,9,9d,6 uM,006u,6e-6,4,5Fluor2_006u_exp070222_run060522_06,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Anti metabolite (thymidylate synthase inhibitor),Pyrimidine antagonist,5-Fluorouracil,5Fluor,TRUE,2022-02-07,2022-05-06,9,9d,6 uM,006u,6e-6,4,5Fluor3_006u_exp070222_run060522_07,NA
exp070222,exp070222.tsv,Chemotherapy,Chemotherapy,Anti metabolite (thymidylate synthase inhibitor),Pyrimidine antagonist,5-Fluorouracil,5Fluor,TRUE,2022-02-07,2022-05-06,9,9d,6 uM,006u,6e-6,4,5Fluor4_006u_exp070222_run060522_08,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,"Mitotic inhibitor, Taxane",Mitotic inhibitors,Paclitaxel,Paclit,TRUE,2022-03-22,2022-05-06,9,9d,5 nM,005n,5e-9,4,Paclit1_005n_exp220322_run060522_37,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,"Mitotic inhibitor, Taxane",Mitotic inhibitors,Paclitaxel,Paclit,TRUE,2022-03-22,2022-05-06,9,9d,5 nM,005n,5e-9,4,Paclit2_005n_exp220322_run060522_38,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,"Mitotic inhibitor, Taxane",Mitotic inhibitors,Paclitaxel,Paclit,TRUE,2022-03-22,2022-05-06,9,9d,5 nM,005n,5e-9,4,Paclit3_005n_exp220322_run060522_39,NA
exp220322,exp220322.tsv,Chemotherapy,Chemotherapy,"Mitotic inhibitor, Taxane",Mitotic inhibitors,Paclitaxel,Paclit,TRUE,2022-03-22,2022-05-06,9,9d,5 nM,005n,5e-9,4,Paclit4_005n_exp220322_run060522_40,NA
exp130921,exp130921.tsv,Epigenetics,Epigenetics,DNMT inhibitor,DNMT inhibitor,5-Azacytidine,Azacyt,TRUE,2021-09-13,2021-09-29,9,9d,"1,5 uM",1.50u,1.5e-6,4,Azacyt1_1.50u_exp130921_run290921_40,NA
exp130921,exp130921.tsv,Epigenetics,Epigenetics,DNMT inhibitor,DNMT inhibitor,5-Azacytidine,Azacyt,TRUE,2021-09-13,2021-09-29,9,9d,"1,5 uM",1.50u,1.5e-6,4,Azacyt2_1.50u_exp130921_run290921_41,NA
exp130921,exp130921.tsv,Epigenetics,Epigenetics,DNMT inhibitor,DNMT inhibitor,5-Azacytidine,Azacyt,TRUE,2021-09-13,2021-09-29,9,9d,"1,5 uM",1.50u,1.5e-6,4,Azacyt3_1.50u_exp130921_run290921_42,NA
exp130921,exp130921.tsv,Epigenetics,Epigenetics,DNMT inhibitor,DNMT inhibitor,5-Azacytidine,Azacyt,TRUE,2021-09-13,2021-09-29,9,9d,"1,5 uM",1.50u,1.5e-6,4,Azacyt4_1.50u_exp130921_run290921_43,NA
exp130921,exp130921.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Vorinostat,Vorino,TRUE,2021-09-13,2021-09-29,9,9d,2 uM,002u,2e-6,4,Vorino1_002u_exp130921_run290921_44,NA
exp130921,exp130921.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Vorinostat,Vorino,TRUE,2021-09-13,2021-09-29,9,9d,2 uM,002u,2e-6,4,Vorino2_002u_exp130921_run290921_45,NA
exp130921,exp130921.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Vorinostat,Vorino,TRUE,2021-09-13,2021-09-29,9,9d,2 uM,002u,2e-6,4,Vorino3_002u_exp130921_run290921_46,NA
exp130921,exp130921.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Vorinostat,Vorino,TRUE,2021-09-13,2021-09-29,9,9d,2 uM,002u,2e-6,4,Vorino4_002u_exp130921_run290921_47,NA
exp181021,exp181021.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Sodium phenylbutyrate,phenyl,TRUE,2021-10-18,2021-11-25,9,9d,2 mM,002m,0.002,4,phenyl1_002m_exp181021_run251121_25,NA
exp181021,exp181021.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Sodium phenylbutyrate,phenyl,TRUE,2021-10-18,2021-11-25,9,9d,2 mM,002m,0.002,4,phenyl2_002m_exp181021_run251121_26,NA
exp181021,exp181021.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Sodium phenylbutyrate,phenyl,TRUE,2021-10-18,2021-11-25,9,9d,2 mM,002m,0.002,4,phenyl3_002m_exp181021_run251121_27,NA
exp181021,exp181021.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Sodium phenylbutyrate,phenyl,TRUE,2021-10-18,2021-11-25,9,9d,2 mM,002m,0.002,4,phenyl4_002m_exp181021_run251121_28,NA
exp271221,exp271221.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Sodium butyrate,NaButy,TRUE,2021-12-27,2022-01-18,9,9d,2 mM,002m,0.002,4,NaButy1_002m_exp271221_run180122_33,Low cluster density
exp271221,exp271221.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Sodium butyrate,NaButy,TRUE,2021-12-27,2022-01-18,9,9d,2 mM,002m,0.002,4,NaButy2_002m_exp271221_run180122_34,Low cluster density
exp271221,exp271221.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Sodium butyrate,NaButy,TRUE,2021-12-27,2022-01-18,9,9d,2 mM,002m,0.002,4,NaButy3_002m_exp271221_run180122_35,Low cluster density
exp271221,exp271221.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Sodium butyrate,NaButy,TRUE,2021-12-27,2022-01-18,9,9d,2 mM,002m,0.002,4,NaButy4_002m_exp271221_run180122_36,Low cluster density
exp271221,exp271221.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Trichostatin A,Tricho,TRUE,2021-12-27,2022-01-18,9,9d,110 nM,110n,1.1e-7,4,Tricho1_110n_exp271221_run180122_37,Low cluster density
exp271221,exp271221.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Trichostatin A,Tricho,TRUE,2021-12-27,2022-01-18,9,9d,110 nM,110n,1.1e-7,4,Tricho2_110n_exp271221_run180122_38,Low cluster density
exp271221,exp271221.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Trichostatin A,Tricho,TRUE,2021-12-27,2022-01-18,9,9d,110 nM,110n,1.1e-7,4,Tricho3_110n_exp271221_run180122_39,Low cluster density
exp271221,exp271221.tsv,Epigenetics,Epigenetics,HDAC inhibitor,HDAC inhibitors,Trichostatin A,Tricho,TRUE,2021-12-27,2022-01-18,9,9d,110 nM,110n,1.1e-7,4,Tricho4_110n_exp271221_run180122_40,Low cluster density
exp181021,exp181021.tsv,Epigenetics,Epigenetics,EZH2 inhibitor,EZH2 inhibitor,Tazemetostat,Tazeme,TRUE,2021-10-18,2021-11-25,9,9d,40 uM,040u,3.9999999999999996e-05,4,Tazeme1_040u_exp181021_run251121_21,NA
exp181021,exp181021.tsv,Epigenetics,Epigenetics,EZH2 inhibitor,EZH2 inhibitor,Tazemetostat,Tazeme,TRUE,2021-10-18,2021-11-25,9,9d,40 uM,040u,3.9999999999999996e-05,4,Tazeme2_040u_exp181021_run251121_22,NA
exp181021,exp181021.tsv,Epigenetics,Epigenetics,EZH2 inhibitor,EZH2 inhibitor,Tazemetostat,Tazeme,TRUE,2021-10-18,2021-11-25,9,9d,40 uM,040u,3.9999999999999996e-05,4,Tazeme3_040u_exp181021_run251121_23,NA
exp181021,exp181021.tsv,Epigenetics,Epigenetics,EZH2 inhibitor,EZH2 inhibitor,Tazemetostat,Tazeme,TRUE,2021-10-18,2021-11-25,9,9d,40 uM,040u,3.9999999999999996e-05,4,Tazeme4_040u_exp181021_run251121_24,NA
exp300821,exp300821.tsv,RTK,Epigenetics,"Inhibitor of RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit","RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit",Sorafenib,Sorafe,TRUE,2021-08-30,2021-09-29,9,9d,5 uM,005u,4.9999999999999996e-6,3,Sorafe1_005u_exp300821_run290921_29,Only 3 replicates
exp300821,exp300821.tsv,RTK,Epigenetics,"Inhibitor of RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit","RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit",Sorafenib,Sorafe,TRUE,2021-08-30,2021-09-29,9,9d,5 uM,005u,4.9999999999999996e-6,3,Sorafe2_005u_exp300821_run290921_30,Only 3 replicates
exp300821,exp300821.tsv,RTK,Epigenetics,"Inhibitor of RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit","RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit",Sorafenib,Sorafe,TRUE,2021-08-30,2021-09-29,9,9d,5 uM,005u,4.9999999999999996e-6,3,Sorafe3_005u_exp300821_run290921_31,Only 3 replicates
exp151121,exp151121.tsv,RTK,Epigenetics,"Inhibitor of RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit","RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit",Sorafenib,Sorafe,TRUE,2021-11-15,2021-12-07,9,9d,5 uM,005u,4.9999999999999996e-6,4,Sorafe1_005u_exp151121_run071221_33,NA
exp151121,exp151121.tsv,RTK,Epigenetics,"Inhibitor of RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit","RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit",Sorafenib,Sorafe,TRUE,2021-11-15,2021-12-07,9,9d,5 uM,005u,4.9999999999999996e-6,4,Sorafe2_005u_exp151121_run071221_34,NA
exp151121,exp151121.tsv,RTK,Epigenetics,"Inhibitor of RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit","RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit",Sorafenib,Sorafe,TRUE,2021-11-15,2021-12-07,9,9d,5 uM,005u,4.9999999999999996e-6,4,Sorafe3_005u_exp151121_run071221_35,NA
exp151121,exp151121.tsv,RTK,Epigenetics,"Inhibitor of RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit","RAF, VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit",Sorafenib,Sorafe,TRUE,2021-11-15,2021-12-07,9,9d,5 uM,005u,4.9999999999999996e-6,4,Sorafe4_005u_exp151121_run071221_36,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET","VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET",Lenvatinib,Lenvat,TRUE,2021-10-18,2021-11-25,9,9d,40 uM,040u,3.9999999999999996e-05,4,Lenvat1_040u_exp181021_run251121_29,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET","VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET",Lenvatinib,Lenvat,TRUE,2021-10-18,2021-11-25,9,9d,40 uM,040u,3.9999999999999996e-05,4,Lenvat2_040u_exp181021_run251121_30,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET","VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET",Lenvatinib,Lenvat,TRUE,2021-10-18,2021-11-25,9,9d,40 uM,040u,3.9999999999999996e-05,4,Lenvat3_040u_exp181021_run251121_31,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET","VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET",Lenvatinib,Lenvat,TRUE,2021-10-18,2021-11-25,9,9d,40 uM,040u,3.9999999999999996e-05,4,Lenvat4_040u_exp181021_run251121_32,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1","VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1",Regorafenib,Regora,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,Regora1_010u_exp181021_run251121_33,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1","VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1",Regorafenib,Regora,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,Regora2_010u_exp181021_run251121_34,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1","VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1",Regorafenib,Regora,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,Regora3_010u_exp181021_run251121_35,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1","VEGFR1/2/3, PDGFRβ, Kit, RET and RAF-1",Regorafenib,Regora,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,Regora4_010u_exp181021_run251121_36,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of  VEGFR2, MET, Kit, Axl and Flt3","VEGFR2, c-Met, Kit, Axl and Flt3",Cabozantinib,Caboza,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,Caboza1_010u_exp181021_run251121_37,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of  VEGFR2, MET, Kit, Axl and Flt3","VEGFR2, c-Met, Kit, Axl and Flt3",Cabozantinib,Caboza,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,Caboza2_010u_exp181021_run251121_38,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of  VEGFR2, MET, Kit, Axl and Flt3","VEGFR2, c-Met, Kit, Axl and Flt3",Cabozantinib,Caboza,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,Caboza3_010u_exp181021_run251121_39,NA
exp181021,exp181021.tsv,RTK,Epigenetics,"Inhibitor of  VEGFR2, MET, Kit, Axl and Flt3","VEGFR2, c-Met, Kit, Axl and Flt3",Cabozantinib,Caboza,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,Caboza4_010u_exp181021_run251121_40,NA
exp271221,exp271221.tsv,RTK,Epigenetics,"Inhibitor of VEGFR, PDGFR, Kit, RET",VEGFR2 and PDGFRβ,Sunitinib,Suniti,TRUE,2021-12-27,2022-01-14,9,9d,15 uM,015u,1.4999999999999999e-5,4,Suniti1_015u_exp271221_run140122_21,Low cluster density
exp271221,exp271221.tsv,RTK,Epigenetics,"Inhibitor of VEGFR, PDGFR, Kit, RET",VEGFR2 and PDGFRβ,Sunitinib,Suniti,TRUE,2021-12-27,2022-01-14,9,9d,15 uM,015u,1.4999999999999999e-5,4,Suniti2_015u_exp271221_run140122_22,Low cluster density
exp271221,exp271221.tsv,RTK,Epigenetics,"Inhibitor of VEGFR, PDGFR, Kit, RET",VEGFR2 and PDGFRβ,Sunitinib,Suniti,TRUE,2021-12-27,2022-01-14,9,9d,15 uM,015u,1.4999999999999999e-5,4,Suniti3_015u_exp271221_run140122_23,Low cluster density
exp271221,exp271221.tsv,RTK,Epigenetics,"Inhibitor of VEGFR, PDGFR, Kit, RET",VEGFR2 and PDGFRβ,Sunitinib,Suniti,TRUE,2021-12-27,2022-01-14,9,9d,15 uM,015u,1.4999999999999999e-5,4,Suniti4_015u_exp271221_run140122_24,Low cluster density
exp300821,exp300821.tsv,Apoptosis,Apoptosis,BCL-2 inhibitor,BCL-2 inhibitor,Navitoclax,Navito,TRUE,2021-08-30,2021-09-29,9,9d,6 uM,006u,6e-6,4,Navito1_006u_exp300821_run290921_21,NA
exp300821,exp300821.tsv,Apoptosis,Apoptosis,BCL-2 inhibitor,BCL-2 inhibitor,Navitoclax,Navito,TRUE,2021-08-30,2021-09-29,9,9d,6 uM,006u,6e-6,4,Navito2_006u_exp300821_run290921_22,NA
exp300821,exp300821.tsv,Apoptosis,Apoptosis,BCL-2 inhibitor,BCL-2 inhibitor,Navitoclax,Navito,TRUE,2021-08-30,2021-09-29,9,9d,6 uM,006u,6e-6,4,Navito3_006u_exp300821_run290921_23,NA
exp300821,exp300821.tsv,Apoptosis,Apoptosis,BCL-2 inhibitor,BCL-2 inhibitor,Navitoclax,Navito,TRUE,2021-08-30,2021-09-29,9,9d,6 uM,006u,6e-6,4,Navito4_006u_exp300821_run290921_24,NA
exp271221,exp271221.tsv,Apoptosis,Apoptosis,MCL-1 inhibitor,MCL-1 inhibitor,S63845,S63845,TRUE,2021-12-27,2022-01-14,9,9d,10 uM,010u,9.999999999999999e-6,4,S638451_010u_exp271221_run140122_29,Low cluster density
exp271221,exp271221.tsv,Apoptosis,Apoptosis,MCL-1 inhibitor,MCL-1 inhibitor,S63845,S63845,TRUE,2021-12-27,2022-01-14,9,9d,10 uM,010u,9.999999999999999e-6,4,S638452_010u_exp271221_run140122_30,Low cluster density
exp271221,exp271221.tsv,Apoptosis,Apoptosis,MCL-1 inhibitor,MCL-1 inhibitor,S63845,S63845,TRUE,2021-12-27,2022-01-14,9,9d,10 uM,010u,9.999999999999999e-6,4,S638453_010u_exp271221_run140122_31,Low cluster density
exp271221,exp271221.tsv,Apoptosis,Apoptosis,MCL-1 inhibitor,MCL-1 inhibitor,S63845,S63845,TRUE,2021-12-27,2022-01-14,9,9d,10 uM,010u,9.999999999999999e-6,4,S638454_010u_exp271221_run140122_32,Low cluster density
exp130921,exp130921.tsv,JAK/STAT,JAK/STAT,STAT3 inhibitor,Stat3 inhibitor,Napabucasin,Napabu,TRUE,2021-09-13,2021-10-11,9,9d,1 uM,001u,1e-6,4,Napabu1_001u_exp130921_run111021_01,NA
exp130921,exp130921.tsv,JAK/STAT,JAK/STAT,STAT3 inhibitor,Stat3 inhibitor,Napabucasin,Napabu,TRUE,2021-09-13,2021-10-11,9,9d,1 uM,001u,1e-6,4,Napabu2_001u_exp130921_run111021_02,NA
exp130921,exp130921.tsv,JAK/STAT,JAK/STAT,STAT3 inhibitor,Stat3 inhibitor,Napabucasin,Napabu,TRUE,2021-09-13,2021-10-11,9,9d,1 uM,001u,1e-6,4,Napabu3_001u_exp130921_run111021_03,NA
exp130921,exp130921.tsv,JAK/STAT,JAK/STAT,STAT3 inhibitor,Stat3 inhibitor,Napabucasin,Napabu,TRUE,2021-09-13,2021-10-11,9,9d,1 uM,001u,1e-6,4,Napabu4_001u_exp130921_run111021_04,NA
exp151121,exp151121.tsv,JAK/STAT,JAK/STAT,STAT3 inhibitor,Stat3 inhibitor,"Stat3 inhibitor V, stattic",statti,TRUE,2021-11-15,2022-01-18,9,9d,7 uM,007u,7e-6,4,statti1_007u_exp151121_run180122_11,Low cluster density
exp151121,exp151121.tsv,JAK/STAT,JAK/STAT,STAT3 inhibitor,Stat3 inhibitor,"Stat3 inhibitor V, stattic",statti,TRUE,2021-11-15,2022-01-18,9,9d,7 uM,007u,7e-6,4,statti2_007u_exp151121_run180122_12,Low cluster density
exp151121,exp151121.tsv,JAK/STAT,JAK/STAT,STAT3 inhibitor,Stat3 inhibitor,"Stat3 inhibitor V, stattic",statti,TRUE,2021-11-15,2022-01-18,9,9d,7 uM,007u,7e-6,4,statti3_007u_exp151121_run180122_13,Low cluster density
exp151121,exp151121.tsv,JAK/STAT,JAK/STAT,STAT3 inhibitor,Stat3 inhibitor,"Stat3 inhibitor V, stattic",statti,TRUE,2021-11-15,2022-01-18,9,9d,7 uM,007u,7e-6,4,statti4_007u_exp151121_run180122_14,Low cluster density
exp130921,exp130921.tsv,JAK/STAT,JAK/STAT,JAK inhibitor,JAK inhibitor,AZD1480,AZD148,TRUE,2021-09-13,2021-10-11,9,9d,5 uM,005u,4.9999999999999996e-6,4,AZD1481_005u_exp130921_run111021_05,NA
exp130921,exp130921.tsv,JAK/STAT,JAK/STAT,JAK inhibitor,JAK inhibitor,AZD1480,AZD148,TRUE,2021-09-13,2021-10-11,9,9d,5 uM,005u,4.9999999999999996e-6,4,AZD1482_005u_exp130921_run111021_06,NA
exp130921,exp130921.tsv,JAK/STAT,JAK/STAT,JAK inhibitor,JAK inhibitor,AZD1480,AZD148,TRUE,2021-09-13,2021-10-11,9,9d,5 uM,005u,4.9999999999999996e-6,4,AZD1483_005u_exp130921_run111021_07,NA
exp130921,exp130921.tsv,JAK/STAT,JAK/STAT,JAK inhibitor,JAK inhibitor,AZD1480,AZD148,TRUE,2021-09-13,2021-10-11,9,9d,5 uM,005u,4.9999999999999996e-6,4,AZD1484_005u_exp130921_run111021_08,NA
exp200921,exp200921.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,Bortezomib,Bortez,TRUE,2021-09-20,2021-10-11,9,9d,20 nM,020n,2e-8,4,Bortez1_020n_exp200921_run111021_25,NA
exp200921,exp200921.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,Bortezomib,Bortez,TRUE,2021-09-20,2021-10-11,9,9d,20 nM,020n,2e-8,4,Bortez2_020n_exp200921_run111021_26,NA
exp200921,exp200921.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,Bortezomib,Bortez,TRUE,2021-09-20,2021-10-11,9,9d,20 nM,020n,2e-8,4,Bortez3_020n_exp200921_run111021_27,NA
exp200921,exp200921.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,Bortezomib,Bortez,TRUE,2021-09-20,2021-10-11,9,9d,20 nM,020n,2e-8,4,Bortez4_020n_exp200921_run111021_28,NA
exp271221,exp271221.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,Bortezomib,Bortez,TRUE,2021-12-27,2022-01-18,9,9d,20 nM,020n,2e-8,4,Bortez1_020n_exp271221_run180122_41,Low cluster density
exp271221,exp271221.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,Bortezomib,Bortez,TRUE,2021-12-27,2022-01-18,9,9d,20 nM,020n,2e-8,4,Bortez2_020n_exp271221_run180122_42,Low cluster density
exp271221,exp271221.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,Bortezomib,Bortez,TRUE,2021-12-27,2022-01-18,9,9d,20 nM,020n,2e-8,4,Bortez3_020n_exp271221_run180122_43,Low cluster density
exp271221,exp271221.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,Bortezomib,Bortez,TRUE,2021-12-27,2022-01-18,9,9d,20 nM,020n,2e-8,4,Bortez4_020n_exp271221_run180122_44,Low cluster density
exp271221,exp271221.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,MG132,MG132z,TRUE,2021-12-27,2022-01-18,9,9d,510 nM,510n,5.1e-7,4,MG132z1_510n_exp271221_run180122_45,Low cluster density
exp271221,exp271221.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,MG132,MG132z,TRUE,2021-12-27,2022-01-18,9,9d,510 nM,510n,5.1e-7,4,MG132z2_510n_exp271221_run180122_46,Low cluster density
exp271221,exp271221.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,MG132,MG132z,TRUE,2021-12-27,2022-01-18,9,9d,510 nM,510n,5.1e-7,4,MG132z3_510n_exp271221_run180122_47,Low cluster density
exp271221,exp271221.tsv,Proteasome,Proteasomal inhibitors,Proteasome inhibitor,JAK inhibitor,MG132,MG132z,TRUE,2021-12-27,2022-01-18,9,9d,510 nM,510n,5.1e-7,4,MG132z4_510n_exp271221_run180122_48,Low cluster density
exp200921,exp200921.tsv,Autophagy,Autophagy,Inhitor of lysosome degradation,Autophagy and toll-like receptors (TLRs) inhibitor,Chloroquine,Chloro,TRUE,2021-09-20,2021-10-11,9,9d,40 uM,040u,3.9999999999999996e-05,4,Chloro1_040u_exp200921_run111021_41,NA
exp200921,exp200921.tsv,Autophagy,Autophagy,Inhitor of lysosome degradation,Autophagy and toll-like receptors (TLRs) inhibitor,Chloroquine,Chloro,TRUE,2021-09-20,2021-10-11,9,9d,40 uM,040u,3.9999999999999996e-05,4,Chloro2_040u_exp200921_run111021_42,NA
exp200921,exp200921.tsv,Autophagy,Autophagy,Inhitor of lysosome degradation,Autophagy and toll-like receptors (TLRs) inhibitor,Chloroquine,Chloro,TRUE,2021-09-20,2021-10-11,9,9d,40 uM,040u,3.9999999999999996e-05,4,Chloro3_040u_exp200921_run111021_43,NA
exp200921,exp200921.tsv,Autophagy,Autophagy,Inhitor of lysosome degradation,Autophagy and toll-like receptors (TLRs) inhibitor,Chloroquine,Chloro,TRUE,2021-09-20,2021-10-11,9,9d,40 uM,040u,3.9999999999999996e-05,4,Chloro4_040u_exp200921_run111021_44,NA
exp181021,exp181021.tsv,Autophagy,Autophagy,USP10 and USP13 inhibitor,"Ubiquitin-specific peptidases, USP10 and USP13",Spautin-1,Spauti,TRUE,2021-10-18,2021-11-25,9,9d,7 uM,007u,7e-6,4,Spauti1_007u_exp181021_run251121_17,NA
exp181021,exp181021.tsv,Autophagy,Autophagy,USP10 and USP13 inhibitor,"Ubiquitin-specific peptidases, USP10 and USP13",Spautin-1,Spauti,TRUE,2021-10-18,2021-11-25,9,9d,7 uM,007u,7e-6,4,Spauti2_007u_exp181021_run251121_18,NA
exp181021,exp181021.tsv,Autophagy,Autophagy,USP10 and USP13 inhibitor,"Ubiquitin-specific peptidases, USP10 and USP13",Spautin-1,Spauti,TRUE,2021-10-18,2021-11-25,9,9d,7 uM,007u,7e-6,4,Spauti3_007u_exp181021_run251121_19,NA
exp181021,exp181021.tsv,Autophagy,Autophagy,USP10 and USP13 inhibitor,"Ubiquitin-specific peptidases, USP10 and USP13",Spautin-1,Spauti,TRUE,2021-10-18,2021-11-25,9,9d,7 uM,007u,7e-6,4,Spauti4_007u_exp181021_run251121_20,NA
exp181021,exp181021.tsv,Autophagy,Autophagy,ULK1 inhibitor,ULK1 inhibitor,SBI-0206965,SBI020,TRUE,2021-10-18,2021-11-25,9,9d,5 uM,005u,4.9999999999999996e-6,4,SBI0201_005u_exp181021_run251121_13,NA
exp181021,exp181021.tsv,Autophagy,Autophagy,ULK1 inhibitor,ULK1 inhibitor,SBI-0206965,SBI020,TRUE,2021-10-18,2021-11-25,9,9d,5 uM,005u,4.9999999999999996e-6,4,SBI0202_005u_exp181021_run251121_14,NA
exp181021,exp181021.tsv,Autophagy,Autophagy,ULK1 inhibitor,ULK1 inhibitor,SBI-0206965,SBI020,TRUE,2021-10-18,2021-11-25,9,9d,5 uM,005u,4.9999999999999996e-6,4,SBI0203_005u_exp181021_run251121_15,NA
exp181021,exp181021.tsv,Autophagy,Autophagy,ULK1 inhibitor,ULK1 inhibitor,SBI-0206965,SBI020,TRUE,2021-10-18,2021-11-25,9,9d,5 uM,005u,4.9999999999999996e-6,4,SBI0204_005u_exp181021_run251121_16,NA
exp200921,exp200921.tsv,Autophagy,Antibiotics,V-ATPase inhibitor,Inhibit vacuolar H +-ATPase,Bafilomycin-A1,Bafilo,TRUE,2021-09-20,2021-10-11,9,9d,"1,2 nM",1.20n,1.2e-9,4,Bafilo1_1.20n_exp200921_run111021_45,NA
exp200921,exp200921.tsv,Autophagy,Antibiotics,V-ATPase inhibitor,Inhibit vacuolar H +-ATPase,Bafilomycin-A1,Bafilo,TRUE,2021-09-20,2021-10-11,9,9d,"1,2 nM",1.20n,1.2e-9,4,Bafilo2_1.20n_exp200921_run111021_46,NA
exp200921,exp200921.tsv,Autophagy,Antibiotics,V-ATPase inhibitor,Inhibit vacuolar H +-ATPase,Bafilomycin-A1,Bafilo,TRUE,2021-09-20,2021-10-11,9,9d,"1,2 nM",1.20n,1.2e-9,4,Bafilo3_1.20n_exp200921_run111021_47,NA
exp200921,exp200921.tsv,Autophagy,Antibiotics,V-ATPase inhibitor,Inhibit vacuolar H +-ATPase,Bafilomycin-A1,Bafilo,TRUE,2021-09-20,2021-10-11,9,9d,"1,2 nM",1.20n,1.2e-9,4,Bafilo4_1.20n_exp200921_run111021_48,NA
exp271221,exp271221.tsv,Antibiotics,Antibiotics,Bacterial dihydrofolate reductase inhibitor,Dihydrofolate reductase inhibitor,Trimethoprim,Trimet,TRUE,2021-12-27,2022-01-14,9,9d,600 uM,600u,6e-4,4,Trimet1_600u_exp271221_run140122_33,Low cluster density
exp271221,exp271221.tsv,Antibiotics,Antibiotics,Bacterial dihydrofolate reductase inhibitor,Dihydrofolate reductase inhibitor,Trimethoprim,Trimet,TRUE,2021-12-27,2022-01-14,9,9d,600 uM,600u,6e-4,4,Trimet2_600u_exp271221_run140122_34,Low cluster density
exp271221,exp271221.tsv,Antibiotics,Antibiotics,Bacterial dihydrofolate reductase inhibitor,Dihydrofolate reductase inhibitor,Trimethoprim,Trimet,TRUE,2021-12-27,2022-01-14,9,9d,600 uM,600u,6e-4,4,Trimet3_600u_exp271221_run140122_35,Low cluster density
exp271221,exp271221.tsv,Antibiotics,Antibiotics,Bacterial dihydrofolate reductase inhibitor,Dihydrofolate reductase inhibitor,Trimethoprim,Trimet,TRUE,2021-12-27,2022-01-14,9,9d,600 uM,600u,6e-4,4,Trimet4_600u_exp271221_run140122_36,Low cluster density
exp070222,exp070222.tsv,Antibiotics,Antibiotics,"Ionophore, NLRP3 activator",NLRP3 activator,Nigericin,Nigeri,TRUE,2022-02-07,2022-05-06,9,9d,100 nM,100n,1.0000000000000001e-7,4,Nigeri1_100n_exp070222_run060522_17,NA
exp070222,exp070222.tsv,Antibiotics,Antibiotics,"Ionophore, NLRP3 activator",NLRP3 activator,Nigericin,Nigeri,TRUE,2022-02-07,2022-05-06,9,9d,100 nM,100n,1.0000000000000001e-7,4,Nigeri2_100n_exp070222_run060522_18,NA
exp070222,exp070222.tsv,Antibiotics,Antibiotics,"Ionophore, NLRP3 activator",NLRP3 activator,Nigericin,Nigeri,TRUE,2022-02-07,2022-05-06,9,9d,100 nM,100n,1.0000000000000001e-7,4,Nigeri3_100n_exp070222_run060522_19,NA
exp070222,exp070222.tsv,Antibiotics,Antibiotics,"Ionophore, NLRP3 activator",NLRP3 activator,Nigericin,Nigeri,TRUE,2022-02-07,2022-05-06,9,9d,100 nM,100n,1.0000000000000001e-7,4,Nigeri4_100n_exp070222_run060522_20,NA
exp181021,exp181021.tsv,Translation initiation,MNK,MNK1/MNK2 inhibitor,MNK1 and MNK2 inhibitor,eFT-508,eFT508,TRUE,2021-10-18,2021-11-25,9,9d,25 uM,025u,2.4999999999999998e-5,4,eFT5081_025u_exp181021_run251121_45,NA
exp181021,exp181021.tsv,Translation initiation,MNK,MNK1/MNK2 inhibitor,MNK1 and MNK2 inhibitor,eFT-508,eFT508,TRUE,2021-10-18,2021-11-25,9,9d,25 uM,025u,2.4999999999999998e-5,4,eFT5082_025u_exp181021_run251121_46,NA
exp181021,exp181021.tsv,Translation initiation,MNK,MNK1/MNK2 inhibitor,MNK1 and MNK2 inhibitor,eFT-508,eFT508,TRUE,2021-10-18,2021-11-25,9,9d,25 uM,025u,2.4999999999999998e-5,4,eFT5083_025u_exp181021_run251121_47,NA
exp181021,exp181021.tsv,Translation initiation,MNK,MNK1/MNK2 inhibitor,MNK1 and MNK2 inhibitor,eFT-508,eFT508,TRUE,2021-10-18,2021-11-25,9,9d,25 uM,025u,2.4999999999999998e-5,4,eFT5084_025u_exp181021_run251121_48,NA
exp181021,exp181021.tsv,Translation initiation,MNK,MNK1 inhibitor,MNK1 inhibitor,CGP57380,CGP573,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,CGP5731_010u_exp181021_run251121_41,NA
exp181021,exp181021.tsv,Translation initiation,MNK,MNK1 inhibitor,MNK1 inhibitor,CGP57380,CGP573,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,CGP5732_010u_exp181021_run251121_42,NA
exp181021,exp181021.tsv,Translation initiation,MNK,MNK1 inhibitor,MNK1 inhibitor,CGP57380,CGP573,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,CGP5733_010u_exp181021_run251121_43,NA
exp181021,exp181021.tsv,Translation initiation,MNK,MNK1 inhibitor,MNK1 inhibitor,CGP57380,CGP573,TRUE,2021-10-18,2021-11-25,9,9d,10 uM,010u,9.999999999999999e-6,4,CGP5734_010u_exp181021_run251121_44,NA
exp200921,exp200921.tsv,AMPK,AMPK,AMPK inhibitor,AMPK inhibitor,Dorsomorphin,Compou,TRUE,2021-09-20,2021-10-11,9,9d,8 uM,008u,8e-6,4,Compou1_008u_exp200921_run111021_17,NA
exp200921,exp200921.tsv,AMPK,AMPK,AMPK inhibitor,AMPK inhibitor,Dorsomorphin,Compou,TRUE,2021-09-20,2021-10-11,9,9d,8 uM,008u,8e-6,4,Compou2_008u_exp200921_run111021_18,NA
exp200921,exp200921.tsv,AMPK,AMPK,AMPK inhibitor,AMPK inhibitor,Dorsomorphin,Compou,TRUE,2021-09-20,2021-10-11,9,9d,8 uM,008u,8e-6,4,Compou3_008u_exp200921_run111021_19,NA
exp200921,exp200921.tsv,AMPK,AMPK,AMPK inhibitor,AMPK inhibitor,Dorsomorphin,Compou,TRUE,2021-09-20,2021-10-11,9,9d,8 uM,008u,8e-6,4,Compou4_008u_exp200921_run111021_20,NA
exp271221,exp271221.tsv,cAMP,AMPK,cAMP phosphodiesterase inhibitor,AMP phosphodiesterase (PDE) inhibitor,Ibudilast,Ibudil,TRUE,2021-12-27,2022-01-14,9,9d,400 uM,400u,3.9999999999999996e-4,4,Ibudil1_400u_exp271221_run140122_45,Low cluster density
exp271221,exp271221.tsv,cAMP,AMPK,cAMP phosphodiesterase inhibitor,AMP phosphodiesterase (PDE) inhibitor,Ibudilast,Ibudil,TRUE,2021-12-27,2022-01-14,9,9d,400 uM,400u,3.9999999999999996e-4,4,Ibudil2_400u_exp271221_run140122_46,Low cluster density
exp271221,exp271221.tsv,cAMP,AMPK,cAMP phosphodiesterase inhibitor,AMP phosphodiesterase (PDE) inhibitor,Ibudilast,Ibudil,TRUE,2021-12-27,2022-01-14,9,9d,400 uM,400u,3.9999999999999996e-4,4,Ibudil3_400u_exp271221_run140122_47,Low cluster density
exp271221,exp271221.tsv,cAMP,AMPK,cAMP phosphodiesterase inhibitor,AMP phosphodiesterase (PDE) inhibitor,Ibudilast,Ibudil,TRUE,2021-12-27,2022-01-14,9,9d,400 uM,400u,3.9999999999999996e-4,4,Ibudil4_400u_exp271221_run140122_48,Low cluster density
exp151121,exp151121.tsv,AMPK,AMPK,AMPK activator,AMPK activator,Phenformin,Phenfo,TRUE,2021-11-15,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,Phenfo1_050u_exp151121_run180122_03,Low cluster density
exp151121,exp151121.tsv,AMPK,AMPK,AMPK activator,AMPK activator,Phenformin,Phenfo,TRUE,2021-11-15,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,Phenfo2_050u_exp151121_run180122_04,Low cluster density
exp151121,exp151121.tsv,AMPK,AMPK,AMPK activator,AMPK activator,Phenformin,Phenfo,TRUE,2021-11-15,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,Phenfo3_050u_exp151121_run180122_05,Low cluster density
exp151121,exp151121.tsv,AMPK,AMPK,AMPK activator,AMPK activator,Phenformin,Phenfo,TRUE,2021-11-15,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,Phenfo4_050u_exp151121_run180122_06,Low cluster density
exp200921,exp200921.tsv,RhoA/ROCK/LIMK,ROCK,LIMK inhibitor,LIMK inhibitor,LIM Kinase Inhibitor I,LIMKi3,TRUE,2021-09-20,2021-10-11,9,9d,30 uM,030u,2.9999999999999997e-5,4,LIMKi31_030u_exp200921_run111021_21,NA
exp200921,exp200921.tsv,RhoA/ROCK/LIMK,ROCK,LIMK inhibitor,LIMK inhibitor,LIM Kinase Inhibitor I,LIMKi3,TRUE,2021-09-20,2021-10-11,9,9d,30 uM,030u,2.9999999999999997e-5,4,LIMKi32_030u_exp200921_run111021_22,NA
exp200921,exp200921.tsv,RhoA/ROCK/LIMK,ROCK,LIMK inhibitor,LIMK inhibitor,LIM Kinase Inhibitor I,LIMKi3,TRUE,2021-09-20,2021-10-11,9,9d,30 uM,030u,2.9999999999999997e-5,4,LIMKi33_030u_exp200921_run111021_23,NA
exp200921,exp200921.tsv,RhoA/ROCK/LIMK,ROCK,LIMK inhibitor,LIMK inhibitor,LIM Kinase Inhibitor I,LIMKi3,TRUE,2021-09-20,2021-10-11,9,9d,30 uM,030u,2.9999999999999997e-5,4,LIMKi34_030u_exp200921_run111021_24,NA
exp070222,exp070222.tsv,RhoA/ROCK/LIMK,ROCK,ROCK-I and ROCK-II inhibitor,ROCK-I and ROCK-II inhibitor,Y-27632,Y27632,TRUE,2022-02-07,2022-05-06,9,9d,300 uM,300u,3e-4,4,Y276321_300u_exp070222_run060522_21,NA
exp070222,exp070222.tsv,RhoA/ROCK/LIMK,ROCK,ROCK-I and ROCK-II inhibitor,ROCK-I and ROCK-II inhibitor,Y-27632,Y27632,TRUE,2022-02-07,2022-05-06,9,9d,300 uM,300u,3e-4,4,Y276322_300u_exp070222_run060522_22,NA
exp070222,exp070222.tsv,RhoA/ROCK/LIMK,ROCK,ROCK-I and ROCK-II inhibitor,ROCK-I and ROCK-II inhibitor,Y-27632,Y27632,TRUE,2022-02-07,2022-05-06,9,9d,300 uM,300u,3e-4,4,Y276323_300u_exp070222_run060522_23,NA
exp070222,exp070222.tsv,RhoA/ROCK/LIMK,ROCK,ROCK-I and ROCK-II inhibitor,ROCK-I and ROCK-II inhibitor,Y-27632,Y27632,TRUE,2022-02-07,2022-05-06,9,9d,300 uM,300u,3e-4,4,Y276324_300u_exp070222_run060522_24,NA
exp200921,exp200921.tsv,CDK,CDK,CDK4/CDK6 inhibitor,CDK4/CDK6 inhibitor,Palbociclib,Palboc,TRUE,2021-09-20,2021-10-11,9,9d,10 uM,010u,9.999999999999999e-6,4,Palboc1_010u_exp200921_run111021_29,NA
exp200921,exp200921.tsv,CDK,CDK,CDK4/CDK6 inhibitor,CDK4/CDK6 inhibitor,Palbociclib,Palboc,TRUE,2021-09-20,2021-10-11,9,9d,10 uM,010u,9.999999999999999e-6,4,Palboc2_010u_exp200921_run111021_30,NA
exp200921,exp200921.tsv,CDK,CDK,CDK4/CDK6 inhibitor,CDK4/CDK6 inhibitor,Palbociclib,Palboc,TRUE,2021-09-20,2021-10-11,9,9d,10 uM,010u,9.999999999999999e-6,4,Palboc3_010u_exp200921_run111021_31,NA
exp200921,exp200921.tsv,CDK,CDK,CDK4/CDK6 inhibitor,CDK4/CDK6 inhibitor,Palbociclib,Palboc,TRUE,2021-09-20,2021-10-11,9,9d,10 uM,010u,9.999999999999999e-6,4,Palboc4_010u_exp200921_run111021_32,NA
exp220322,exp220322.tsv,CDK,CDK,CDK7 inhibitor,CDK7 inhibitor,THZ1,THZ1,TRUE,2022-03-22,2022-05-20,9,9d,90 nM,090n,9.000000000000001e-8,4,THZ11_090n_exp220322_run200522_09,NA
exp220322,exp220322.tsv,CDK,CDK,CDK7 inhibitor,CDK7 inhibitor,THZ1,THZ1,TRUE,2022-03-22,2022-05-20,9,9d,90 nM,090n,9.000000000000001e-8,4,THZ12_090n_exp220322_run200522_10,NA
exp220322,exp220322.tsv,CDK,CDK,CDK7 inhibitor,CDK7 inhibitor,THZ1,THZ1,TRUE,2022-03-22,2022-05-20,9,9d,90 nM,090n,9.000000000000001e-8,4,THZ13_090n_exp220322_run200522_11,NA
exp220322,exp220322.tsv,CDK,CDK,CDK7 inhibitor,CDK7 inhibitor,THZ1,THZ1,TRUE,2022-03-22,2022-05-20,9,9d,90 nM,090n,9.000000000000001e-8,4,THZ14_090n_exp220322_run200522_12,NA
exp200921,exp200921.tsv,PARP,PARP,PARP1/2 inhibitor,PARP1/2 inhibitor,Olaparib,Olapar,TRUE,2021-09-20,2021-10-11,9,9d,20 uM,020u,1.9999999999999998e-5,4,Olapar1_020u_exp200921_run111021_33,NA
exp200921,exp200921.tsv,PARP,PARP,PARP1/2 inhibitor,PARP1/2 inhibitor,Olaparib,Olapar,TRUE,2021-09-20,2021-10-11,9,9d,20 uM,020u,1.9999999999999998e-5,4,Olapar2_020u_exp200921_run111021_34,NA
exp200921,exp200921.tsv,PARP,PARP,PARP1/2 inhibitor,PARP1/2 inhibitor,Olaparib,Olapar,TRUE,2021-09-20,2021-10-11,9,9d,20 uM,020u,1.9999999999999998e-5,4,Olapar3_020u_exp200921_run111021_35,NA
exp200921,exp200921.tsv,PARP,PARP,PARP1/2 inhibitor,PARP1/2 inhibitor,Olaparib,Olapar,TRUE,2021-09-20,2021-10-11,9,9d,20 uM,020u,1.9999999999999998e-5,4,Olapar4_020u_exp200921_run111021_36,NA
exp220322,exp220322.tsv,Wnt,Wnt,Tankyrase inhibitor,Tankyrase inhibitor,XAV-939,XAV939,TRUE,2022-03-22,2022-05-06,9,9d,80 uM,080u,7.999999999999999e-5,4,XAV9391_080u_exp220322_run060522_45,"4 are reported, only 2 could be found in the provided csv file"
exp220322,exp220322.tsv,Wnt,Wnt,Tankyrase inhibitor,Tankyrase inhibitor,XAV-939,XAV939,TRUE,2022-03-22,2022-05-06,9,9d,80 uM,080u,7.999999999999999e-5,4,XAV9392_080u_exp220322_run060522_46,"4 are reported, only 2 could be found in the provided csv file"
exp220322,exp220322.tsv,Wnt,Wnt,Tankyrase inhibitor,Tankyrase inhibitor,XAV-939,XAV939,TRUE,2022-03-22,2022-05-06,9,9d,80 uM,080u,7.999999999999999e-5,4,XAV9393_080u_exp220322_run060522_47,"4 are reported, only 2 could be found in the provided csv file"
exp220322,exp220322.tsv,Wnt,Wnt,Tankyrase inhibitor,Tankyrase inhibitor,XAV-939,XAV939,TRUE,2022-03-22,2022-05-06,9,9d,80 uM,080u,7.999999999999999e-5,4,XAV9394_080u_exp220322_run060522_48,"4 are reported, only 2 could be found in the provided csv file"
exp200921,exp200921.tsv,Wnt,Wnt,Porcupine inhibitor,Porcupine inhibitor,LGK974,LGK974,TRUE,2021-09-20,2021-10-11,9,9d,5 uM,005u,4.9999999999999996e-6,4,LGK9741_005u_exp200921_run111021_37,NA
exp200921,exp200921.tsv,Wnt,Wnt,Porcupine inhibitor,Porcupine inhibitor,LGK974,LGK974,TRUE,2021-09-20,2021-10-11,9,9d,5 uM,005u,4.9999999999999996e-6,4,LGK9742_005u_exp200921_run111021_38,NA
exp200921,exp200921.tsv,Wnt,Wnt,Porcupine inhibitor,Porcupine inhibitor,LGK974,LGK974,TRUE,2021-09-20,2021-10-11,9,9d,5 uM,005u,4.9999999999999996e-6,4,LGK9743_005u_exp200921_run111021_39,NA
exp200921,exp200921.tsv,Wnt,Wnt,Porcupine inhibitor,Porcupine inhibitor,LGK974,LGK974,TRUE,2021-09-20,2021-10-11,9,9d,5 uM,005u,4.9999999999999996e-6,4,LGK9744_005u_exp200921_run111021_40,NA
exp151121,exp151121.tsv,Calcium,CaM-KK,CaM-KK inhibitor,CaM-KK inhibitor,STO-609,STO609,TRUE,2021-11-15,2021-12-07,9,9d,30 uM,030u,2.9999999999999997e-5,4,STO6091_030u_exp151121_run071221_41,NA
exp151121,exp151121.tsv,Calcium,CaM-KK,CaM-KK inhibitor,CaM-KK inhibitor,STO-609,STO609,TRUE,2021-11-15,2021-12-07,9,9d,30 uM,030u,2.9999999999999997e-5,4,STO6092_030u_exp151121_run071221_42,NA
exp151121,exp151121.tsv,Calcium,CaM-KK,CaM-KK inhibitor,CaM-KK inhibitor,STO-609,STO609,TRUE,2021-11-15,2021-12-07,9,9d,30 uM,030u,2.9999999999999997e-5,4,STO6093_030u_exp151121_run071221_43,NA
exp151121,exp151121.tsv,Calcium,CaM-KK,CaM-KK inhibitor,CaM-KK inhibitor,STO-609,STO609,TRUE,2021-11-15,2021-12-07,9,9d,30 uM,030u,2.9999999999999997e-5,4,STO6094_030u_exp151121_run071221_44,NA
exp151121,exp151121.tsv,PI3K/AKT/mTOR,AKT,AKT inhibitor,AKT inhibitor,Capivasertib (AZD5363),Capiva,TRUE,2021-11-15,2021-12-07,9,9d,50 uM,050u,4.9999999999999996e-5,4,Capiva1_050u_exp151121_run071221_45,NA
exp151121,exp151121.tsv,PI3K/AKT/mTOR,AKT,AKT inhibitor,AKT inhibitor,Capivasertib (AZD5363),Capiva,TRUE,2021-11-15,2021-12-07,9,9d,50 uM,050u,4.9999999999999996e-5,4,Capiva2_050u_exp151121_run071221_46,NA
exp151121,exp151121.tsv,PI3K/AKT/mTOR,AKT,AKT inhibitor,AKT inhibitor,Capivasertib (AZD5363),Capiva,TRUE,2021-11-15,2021-12-07,9,9d,50 uM,050u,4.9999999999999996e-5,4,Capiva3_050u_exp151121_run071221_47,NA
exp151121,exp151121.tsv,PI3K/AKT/mTOR,AKT,AKT inhibitor,AKT inhibitor,Capivasertib (AZD5363),Capiva,TRUE,2021-11-15,2021-12-07,9,9d,50 uM,050u,4.9999999999999996e-5,4,Capiva4_050u_exp151121_run071221_48,NA
exp271221,exp271221.tsv,RAS-MAPK,ERK1/RasGAP,ERK1 and RasGAP inhibitor,ERK1 and RasGAP inhibitor,Pluripotin (SC-1),Plurip,TRUE,2021-12-27,2022-01-14,9,9d,10 uM,010u,9.999999999999999e-6,4,Plurip1_010u_exp271221_run140122_25,Low cluster density
exp271221,exp271221.tsv,RAS-MAPK,ERK1/RasGAP,ERK1 and RasGAP inhibitor,ERK1 and RasGAP inhibitor,Pluripotin (SC-1),Plurip,TRUE,2021-12-27,2022-01-14,9,9d,10 uM,010u,9.999999999999999e-6,4,Plurip2_010u_exp271221_run140122_26,Low cluster density
exp271221,exp271221.tsv,RAS-MAPK,ERK1/RasGAP,ERK1 and RasGAP inhibitor,ERK1 and RasGAP inhibitor,Pluripotin (SC-1),Plurip,TRUE,2021-12-27,2022-01-14,9,9d,10 uM,010u,9.999999999999999e-6,4,Plurip3_010u_exp271221_run140122_27,Low cluster density
exp271221,exp271221.tsv,RAS-MAPK,ERK1/RasGAP,ERK1 and RasGAP inhibitor,ERK1 and RasGAP inhibitor,Pluripotin (SC-1),Plurip,TRUE,2021-12-27,2022-01-14,9,9d,10 uM,010u,9.999999999999999e-6,4,Plurip4_010u_exp271221_run140122_28,Low cluster density
exp271221,exp271221.tsv,Oxidative stress,Antioxidant,ROS inhibitor,ROS inhibitor,N-Acetyl-L-cysteine (NAC),NAcety,TRUE,2021-12-27,2022-01-14,9,9d,15 mM,015m,0.015,4,NAcety1_015m_exp271221_run140122_37,Low cluster density
exp271221,exp271221.tsv,Oxidative stress,Antioxidant,ROS inhibitor,ROS inhibitor,N-Acetyl-L-cysteine (NAC),NAcety,TRUE,2021-12-27,2022-01-14,9,9d,15 mM,015m,0.015,4,NAcety2_015m_exp271221_run140122_38,Low cluster density
exp271221,exp271221.tsv,Oxidative stress,Antioxidant,ROS inhibitor,ROS inhibitor,N-Acetyl-L-cysteine (NAC),NAcety,TRUE,2021-12-27,2022-01-14,9,9d,15 mM,015m,0.015,4,NAcety3_015m_exp271221_run140122_39,Low cluster density
exp271221,exp271221.tsv,Oxidative stress,Antioxidant,ROS inhibitor,ROS inhibitor,N-Acetyl-L-cysteine (NAC),NAcety,TRUE,2021-12-27,2022-01-14,9,9d,15 mM,015m,0.015,4,NAcety4_015m_exp271221_run140122_40,Low cluster density
exp271221,exp271221.tsv,p53,p53,Inhibition of MDM2-mediated degradation of p53,Inhibition of MDM2-mediated degradation of p53,Nutlin3,Nutlin,TRUE,2021-12-27,2022-01-14,9,9d,25 uM,025u,2.4999999999999998e-5,4,Nutlin1_025u_exp271221_run140122_41,Low cluster density
exp271221,exp271221.tsv,p53,p53,Inhibition of MDM2-mediated degradation of p53,Inhibition of MDM2-mediated degradation of p53,Nutlin3,Nutlin,TRUE,2021-12-27,2022-01-14,9,9d,25 uM,025u,2.4999999999999998e-5,4,Nutlin2_025u_exp271221_run140122_42,Low cluster density
exp271221,exp271221.tsv,p53,p53,Inhibition of MDM2-mediated degradation of p53,Inhibition of MDM2-mediated degradation of p53,Nutlin3,Nutlin,TRUE,2021-12-27,2022-01-14,9,9d,25 uM,025u,2.4999999999999998e-5,4,Nutlin3_025u_exp271221_run140122_43,Low cluster density
exp271221,exp271221.tsv,p53,p53,Inhibition of MDM2-mediated degradation of p53,Inhibition of MDM2-mediated degradation of p53,Nutlin3,Nutlin,TRUE,2021-12-27,2022-01-14,9,9d,25 uM,025u,2.4999999999999998e-5,4,Nutlin4_025u_exp271221_run140122_44,Low cluster density
exp151121,exp151121.tsv,RTK/RAS-MAPK,SHP2,SHP2 inhibitor,SHP2 inhibitor,SHP099,SHP099,TRUE,2021-11-15,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,SHP0991_050u_exp151121_run180122_07,Low cluster density
exp151121,exp151121.tsv,RTK/RAS-MAPK,SHP2,SHP2 inhibitor,SHP2 inhibitor,SHP099,SHP099,TRUE,2021-11-15,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,SHP0992_050u_exp151121_run180122_08,Low cluster density
exp151121,exp151121.tsv,RTK/RAS-MAPK,SHP2,SHP2 inhibitor,SHP2 inhibitor,SHP099,SHP099,TRUE,2021-11-15,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,SHP0993_050u_exp151121_run180122_09,Low cluster density
exp151121,exp151121.tsv,RTK/RAS-MAPK,SHP2,SHP2 inhibitor,SHP2 inhibitor,SHP099,SHP099,TRUE,2021-11-15,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,SHP0994_050u_exp151121_run180122_10,Low cluster density
exp300821,exp300821.tsv,Drug combinations,Drug combinations,EGFR inhibitor + multikinase inhibitor,EGFR-TKI + multikinase inhibitor,Osimertinb+sorafenib,OsiSor,TRUE,2021-08-30,2021-09-29,9,9d,"0,1uM+5uM",015u,1.4999999999999999e-5,4,OsiSor1_015u_exp300821_run290921_09,NA
exp300821,exp300821.tsv,Drug combinations,Drug combinations,EGFR inhibitor + multikinase inhibitor,EGFR-TKI + multikinase inhibitor,Osimertinb+sorafenib,OsiSor,TRUE,2021-08-30,2021-09-29,9,9d,"0,1uM+5uM",015u,1.4999999999999999e-5,4,OsiSor2_015u_exp300821_run290921_10,NA
exp300821,exp300821.tsv,Drug combinations,Drug combinations,EGFR inhibitor + multikinase inhibitor,EGFR-TKI + multikinase inhibitor,Osimertinb+sorafenib,OsiSor,TRUE,2021-08-30,2021-09-29,9,9d,"0,1uM+5uM",015u,1.4999999999999999e-5,4,OsiSor3_015u_exp300821_run290921_11,NA
exp300821,exp300821.tsv,Drug combinations,Drug combinations,EGFR inhibitor + multikinase inhibitor,EGFR-TKI + multikinase inhibitor,Osimertinb+sorafenib,OsiSor,TRUE,2021-08-30,2021-09-29,9,9d,"0,1uM+5uM",015u,1.4999999999999999e-5,4,OsiSor4_015u_exp300821_run290921_12,NA
exp010821,exp010821.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,FALSE,2021-08-01,2021-08-18,9,9d,5 uM,005u,4.9999999999999996e-6,4,X132711_005u_exp010821_run180821_19,5uM concentration was not enough to kill the cells
exp010821,exp010821.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,FALSE,2021-08-01,2021-08-18,9,9d,5 uM,005u,4.9999999999999996e-6,4,X132712_005u_exp010821_run180821_20,5uM concentration was not enough to kill the cells
exp010821,exp010821.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,FALSE,2021-08-01,2021-08-18,9,9d,5 uM,005u,4.9999999999999996e-6,4,X132713_005u_exp010821_run180821_21,5uM concentration was not enough to kill the cells
exp010821,exp010821.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,FALSE,2021-08-01,2021-08-18,9,9d,5 uM,005u,4.9999999999999996e-6,4,X132714_005u_exp010821_run180821_22,5uM concentration was not enough to kill the cells
exp040821,exp040821.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,FALSE,2021-08-04,2021-08-18,9,9d,5 uM,005u,4.9999999999999996e-6,4,X132711_005u_exp040821_run180821_41,5uM concentration was not enough to kill the cells
exp040821,exp040821.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,FALSE,2021-08-04,2021-08-18,9,9d,5 uM,005u,4.9999999999999996e-6,4,X132712_005u_exp040821_run180821_42,5uM concentration was not enough to kill the cells
exp040821,exp040821.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,FALSE,2021-08-04,2021-08-18,9,9d,5 uM,005u,4.9999999999999996e-6,4,X132713_005u_exp040821_run180821_43,5uM concentration was not enough to kill the cells
exp040821,exp040821.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,FALSE,2021-08-04,2021-08-18,9,9d,5 uM,005u,4.9999999999999996e-6,4,X132714_005u_exp040821_run180821_44,5uM concentration was not enough to kill the cells
exp200921,exp200921.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-09-20,2021-10-11,9,9d,8 uM,008u,8e-6,4,X132711_008u_exp200921_run111021_13,Killing was not homogeneous
exp200921,exp200921.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-09-20,2021-10-11,9,9d,8 uM,008u,8e-6,4,X132712_008u_exp200921_run111021_14,Killing was not homogeneous
exp200921,exp200921.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-09-20,2021-10-11,9,9d,8 uM,008u,8e-6,4,X132713_008u_exp200921_run111021_15,Killing was not homogeneous
exp200921,exp200921.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-09-20,2021-10-11,9,9d,8 uM,008u,8e-6,4,X132714_008u_exp200921_run111021_16,Killing was not homogeneous
exp181021,exp181021.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-10-18,2021-11-10,9,9d,8 uM,008u,8e-6,4,X132711_008u_exp181021_run101121_42,Killing was not homogeneous
exp181021,exp181021.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-10-18,2021-11-10,9,9d,8 uM,008u,8e-6,4,X132712_008u_exp181021_run101121_43,Killing was not homogeneous
exp181021,exp181021.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-10-18,2021-11-10,9,9d,8 uM,008u,8e-6,4,X132713_008u_exp181021_run101121_44,Killing was not homogeneous
exp181021,exp181021.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-10-18,2021-11-10,9,9d,8 uM,008u,8e-6,4,X132714_008u_exp181021_run101121_45,Killing was not homogeneous
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-12-27,2022-01-18,9,9d,9 uM,009u,9e-6,4,X132711_009u_exp271221_run180122_21,killing was ok/ Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-12-27,2022-01-18,9,9d,9 uM,009u,9e-6,4,X132712_009u_exp271221_run180122_22,killing was ok/ Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-12-27,2022-01-18,9,9d,9 uM,009u,9e-6,4,X132713_009u_exp271221_run180122_23,killing was ok/ Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X13271,X13271,TRUE,2021-12-27,2022-01-18,9,9d,9 uM,009u,9e-6,4,X132714_009u_exp271221_run180122_24,killing was ok/ Low cluster density
exp181021,exp181021.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X17129,X17129,TRUE,2021-10-18,2021-11-10,9,9d,8 uM,008u,8e-6,3,X171291_008u_exp181021_run101121_46,Killing was not homogeneous
exp181021,exp181021.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X17129,X17129,TRUE,2021-10-18,2021-11-10,9,9d,8 uM,008u,8e-6,3,X171292_008u_exp181021_run101121_47,Killing was not homogeneous
exp181021,exp181021.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X17129,X17129,TRUE,2021-10-18,2021-11-10,9,9d,8 uM,008u,8e-6,3,X171293_008u_exp181021_run101121_48,Killing was not homogeneous
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X17129,X17129,TRUE,2021-12-27,2022-01-18,9,9d,8 uM,008u,8e-6,4,X171291_008u_exp271221_run180122_25,killing was ok/ Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X17129,X17129,TRUE,2021-12-27,2022-01-18,9,9d,8 uM,008u,8e-6,4,X171292_008u_exp271221_run180122_26,killing was ok/ Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X17129,X17129,TRUE,2021-12-27,2022-01-18,9,9d,8 uM,008u,8e-6,4,X171293_008u_exp271221_run180122_27,killing was ok/ Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X17129,X17129,TRUE,2021-12-27,2022-01-18,9,9d,8 uM,008u,8e-6,4,X171294_008u_exp271221_run180122_28,killing was ok/ Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X15681,X15681,TRUE,2021-12-27,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,X156811_050u_exp271221_run180122_29,Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X15681,X15681,TRUE,2021-12-27,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,X156812_050u_exp271221_run180122_30,Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X15681,X15681,TRUE,2021-12-27,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,X156813_050u_exp271221_run180122_31,Low cluster density
exp271221,exp271221.tsv,Novel compound,New compounds from KIT,unknown,EGFR-TKI + multikinase inhibitor,X15681,X15681,TRUE,2021-12-27,2022-01-18,9,9d,50 uM,050u,4.9999999999999996e-5,4,X156814_050u_exp271221_run180122_32,Low cluster density
exp070222,exp070222.tsv,ER stress/UPR,ER stress,Inhibitor of N-glycosylation (DPAGT1 inhibitor),EGFR-TKI + multikinase inhibitor,Tunicamycin,Tunica,TRUE,2022-02-07,2022-03-01,9,9d,"0,5 µg/ml",0.50u,5e-7,4,Tunica1_0.50u_exp070222_run010322_05,NA
exp070222,exp070222.tsv,ER stress/UPR,ER stress,Inhibitor of N-glycosylation (DPAGT1 inhibitor),EGFR-TKI + multikinase inhibitor,Tunicamycin,Tunica,TRUE,2022-02-07,2022-03-01,9,9d,"0,5 µg/ml",0.50u,5e-7,4,Tunica2_0.50u_exp070222_run010322_06,NA
exp070222,exp070222.tsv,ER stress/UPR,ER stress,Inhibitor of N-glycosylation (DPAGT1 inhibitor),EGFR-TKI + multikinase inhibitor,Tunicamycin,Tunica,TRUE,2022-02-07,2022-03-01,9,9d,"0,5 µg/ml",0.50u,5e-7,4,Tunica3_0.50u_exp070222_run010322_07,NA
exp070222,exp070222.tsv,ER stress/UPR,ER stress,Inhibitor of N-glycosylation (DPAGT1 inhibitor),EGFR-TKI + multikinase inhibitor,Tunicamycin,Tunica,TRUE,2022-02-07,2022-03-01,9,9d,"0,5 µg/ml",0.50u,5e-7,4,Tunica4_0.50u_exp070222_run010322_08,NA
exp070222,exp070222.tsv,ER stress/UPR,ER stress,SERCA inhibitor,EGFR-TKI + multikinase inhibitor,Thapsigargin,Thapsi,TRUE,2022-02-07,2022-03-01,9,9d,8 nM,008n,8e-9,4,Thapsi1_008n_exp070222_run010322_09,NA
exp070222,exp070222.tsv,ER stress/UPR,ER stress,SERCA inhibitor,EGFR-TKI + multikinase inhibitor,Thapsigargin,Thapsi,TRUE,2022-02-07,2022-03-01,9,9d,8 nM,008n,8e-9,4,Thapsi2_008n_exp070222_run010322_10,NA
exp070222,exp070222.tsv,ER stress/UPR,ER stress,SERCA inhibitor,EGFR-TKI + multikinase inhibitor,Thapsigargin,Thapsi,TRUE,2022-02-07,2022-03-01,9,9d,8 nM,008n,8e-9,4,Thapsi3_008n_exp070222_run010322_11,NA
exp070222,exp070222.tsv,ER stress/UPR,ER stress,SERCA inhibitor,EGFR-TKI + multikinase inhibitor,Thapsigargin,Thapsi,TRUE,2022-02-07,2022-03-01,9,9d,8 nM,008n,8e-9,4,Thapsi4_008n_exp070222_run010322_12,NA
exp220322,exp220322.tsv,ER stress,ER stress,PERK activator,EGFR-TKI + multikinase inhibitor,CCT020312,CCT020,TRUE,2022-03-22,2022-05-20,9,9d,3 uM,003u,3e-6,4,CCT0201_003u_exp220322_run200522_29,NA
exp220322,exp220322.tsv,ER stress,ER stress,PERK activator,EGFR-TKI + multikinase inhibitor,CCT020312,CCT020,TRUE,2022-03-22,2022-05-20,9,9d,3 uM,003u,3e-6,4,CCT0202_003u_exp220322_run200522_30,NA
exp220322,exp220322.tsv,ER stress,ER stress,PERK activator,EGFR-TKI + multikinase inhibitor,CCT020312,CCT020,TRUE,2022-03-22,2022-05-20,9,9d,3 uM,003u,3e-6,4,CCT0203_003u_exp220322_run200522_31,NA
exp220322,exp220322.tsv,ER stress,ER stress,PERK activator,EGFR-TKI + multikinase inhibitor,CCT020312,CCT020,TRUE,2022-03-22,2022-05-20,9,9d,3 uM,003u,3e-6,4,CCT0204_003u_exp220322_run200522_32,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,VDAC inhibitor,EGFR-TKI + multikinase inhibitor,Erastin,Erasti,TRUE,2022-02-07,2022-03-01,9,9d,15 uM,015u,1.4999999999999999e-5,4,Erasti1_015u_exp070222_run010322_13,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,VDAC inhibitor,EGFR-TKI + multikinase inhibitor,Erastin,Erasti,TRUE,2022-02-07,2022-03-01,9,9d,15 uM,015u,1.4999999999999999e-5,4,Erasti2_015u_exp070222_run010322_14,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,VDAC inhibitor,EGFR-TKI + multikinase inhibitor,Erastin,Erasti,TRUE,2022-02-07,2022-03-01,9,9d,15 uM,015u,1.4999999999999999e-5,4,Erasti3_015u_exp070222_run010322_15,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,VDAC inhibitor,EGFR-TKI + multikinase inhibitor,Erastin,Erasti,TRUE,2022-02-07,2022-03-01,9,9d,15 uM,015u,1.4999999999999999e-5,4,Erasti4_015u_exp070222_run010322_16,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,synthetic antioxidant,EGFR-TKI + multikinase inhibitor,Ferrostatin-1,Ferros,TRUE,2022-02-07,2022-03-01,9,9d,60 uM,060u,5.9999999999999995e-5,4,Ferros1_060u_exp070222_run010322_17,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,synthetic antioxidant,EGFR-TKI + multikinase inhibitor,Ferrostatin-1,Ferros,TRUE,2022-02-07,2022-03-01,9,9d,60 uM,060u,5.9999999999999995e-5,4,Ferros2_060u_exp070222_run010322_18,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,synthetic antioxidant,EGFR-TKI + multikinase inhibitor,Ferrostatin-1,Ferros,TRUE,2022-02-07,2022-03-01,9,9d,60 uM,060u,5.9999999999999995e-5,4,Ferros3_060u_exp070222_run010322_19,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,synthetic antioxidant,EGFR-TKI + multikinase inhibitor,Ferrostatin-1,Ferros,TRUE,2022-02-07,2022-03-01,9,9d,60 uM,060u,5.9999999999999995e-5,4,Ferros4_060u_exp070222_run010322_20,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,Iron chelator,EGFR-TKI + multikinase inhibitor,Deferoxamine,Defero,TRUE,2022-02-07,2022-03-01,9,9d,7 uM,007u,7e-6,4,Defero1_007u_exp070222_run010322_21,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,Iron chelator,EGFR-TKI + multikinase inhibitor,Deferoxamine,Defero,TRUE,2022-02-07,2022-03-01,9,9d,7 uM,007u,7e-6,4,Defero2_007u_exp070222_run010322_22,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,Iron chelator,EGFR-TKI + multikinase inhibitor,Deferoxamine,Defero,TRUE,2022-02-07,2022-03-01,9,9d,7 uM,007u,7e-6,4,Defero3_007u_exp070222_run010322_23,NA
exp070222,exp070222.tsv,Ferroptosis,Ferroptosis,Iron chelator,EGFR-TKI + multikinase inhibitor,Deferoxamine,Defero,TRUE,2022-02-07,2022-03-01,9,9d,7 uM,007u,7e-6,4,Defero4_007u_exp070222_run010322_24,NA
exp070222,exp070222.tsv,Ferroptosis,GPX4,GPX4 inhibitor,EGFR-TKI + multikinase inhibitor,ML-210,ML210-,TRUE,2022-02-07,2022-03-01,9,9d,30 uM,030u,2.9999999999999997e-5,4,ML210-1_030u_exp070222_run010322_25,NA
exp070222,exp070222.tsv,Ferroptosis,GPX4,GPX4 inhibitor,EGFR-TKI + multikinase inhibitor,ML-210,ML210-,TRUE,2022-02-07,2022-03-01,9,9d,30 uM,030u,2.9999999999999997e-5,4,ML210-2_030u_exp070222_run010322_26,NA
exp070222,exp070222.tsv,Ferroptosis,GPX4,GPX4 inhibitor,EGFR-TKI + multikinase inhibitor,ML-210,ML210-,TRUE,2022-02-07,2022-03-01,9,9d,30 uM,030u,2.9999999999999997e-5,4,ML210-3_030u_exp070222_run010322_27,NA
exp070222,exp070222.tsv,Ferroptosis,GPX4,GPX4 inhibitor,EGFR-TKI + multikinase inhibitor,ML-210,ML210-,TRUE,2022-02-07,2022-03-01,9,9d,30 uM,030u,2.9999999999999997e-5,4,ML210-4_030u_exp070222_run010322_28,NA
exp070222,exp070222.tsv,Notch,Notch,Inhibitor of the Notch transcriptional activation complex,EGFR-TKI + multikinase inhibitor,IMR-1,IMR1-,TRUE,2022-02-07,2022-03-01,9,9d,80 uM,080u,7.999999999999999e-5,4,IMR1-1_080u_exp070222_run010322_29,NA
exp070222,exp070222.tsv,Notch,Notch,Inhibitor of the Notch transcriptional activation complex,EGFR-TKI + multikinase inhibitor,IMR-1,IMR1-,TRUE,2022-02-07,2022-03-01,9,9d,80 uM,080u,7.999999999999999e-5,4,IMR1-2_080u_exp070222_run010322_30,NA
exp070222,exp070222.tsv,Notch,Notch,Inhibitor of the Notch transcriptional activation complex,EGFR-TKI + multikinase inhibitor,IMR-1,IMR1-,TRUE,2022-02-07,2022-03-01,9,9d,80 uM,080u,7.999999999999999e-5,4,IMR1-3_080u_exp070222_run010322_31,NA
exp070222,exp070222.tsv,Notch,Notch,Inhibitor of the Notch transcriptional activation complex,EGFR-TKI + multikinase inhibitor,IMR-1,IMR1-,TRUE,2022-02-07,2022-03-01,9,9d,80 uM,080u,7.999999999999999e-5,4,IMR1-4_080u_exp070222_run010322_32,NA
exp220322,exp220322.tsv,Adrenergic receptors,β3-adrenergic receptor partial agonist,beta-3 adrenergic receptor agonist,EGFR-TKI + multikinase inhibitor,L-755507,L75550,TRUE,2022-03-22,2022-05-06,9,9d,25 uM,025u,2.4999999999999998e-5,4,L755501_025u_exp220322_run060522_41,NA
exp220322,exp220322.tsv,Adrenergic receptors,β3-adrenergic receptor partial agonist,beta-3 adrenergic receptor agonist,EGFR-TKI + multikinase inhibitor,L-755507,L75550,TRUE,2022-03-22,2022-05-06,9,9d,25 uM,025u,2.4999999999999998e-5,4,L755502_025u_exp220322_run060522_42,NA
exp220322,exp220322.tsv,Adrenergic receptors,β3-adrenergic receptor partial agonist,beta-3 adrenergic receptor agonist,EGFR-TKI + multikinase inhibitor,L-755507,L75550,TRUE,2022-03-22,2022-05-06,9,9d,25 uM,025u,2.4999999999999998e-5,4,L755503_025u_exp220322_run060522_43,NA
exp220322,exp220322.tsv,Adrenergic receptors,β3-adrenergic receptor partial agonist,beta-3 adrenergic receptor agonist,EGFR-TKI + multikinase inhibitor,L-755507,L75550,TRUE,2022-03-22,2022-05-06,9,9d,25 uM,025u,2.4999999999999998e-5,4,L755504_025u_exp220322_run060522_44,NA
exp220322,exp220322.tsv,Ion transport,Gap junction,"TRPV2 channel agonist, Pannexin 1 inhibitor",Pannexin 1 inhibitor,Probenecid,Proben,TRUE,2022-03-22,2022-05-20,9,9d,500 uM,500u,5e-4,4,Proben1_500u_exp220322_run200522_37,NA
exp220322,exp220322.tsv,Ion transport,Gap junction,"TRPV2 channel agonist, Pannexin 1 inhibitor",Pannexin 1 inhibitor,Probenecid,Proben,TRUE,2022-03-22,2022-05-20,9,9d,500 uM,500u,5e-4,4,Proben2_500u_exp220322_run200522_38,NA
exp220322,exp220322.tsv,Ion transport,Gap junction,"TRPV2 channel agonist, Pannexin 1 inhibitor",Pannexin 1 inhibitor,Probenecid,Proben,TRUE,2022-03-22,2022-05-20,9,9d,500 uM,500u,5e-4,4,Proben3_500u_exp220322_run200522_39,NA
exp220322,exp220322.tsv,Ion transport,Gap junction,"TRPV2 channel agonist, Pannexin 1 inhibitor",Pannexin 1 inhibitor,Probenecid,Proben,TRUE,2022-03-22,2022-05-20,9,9d,500 uM,500u,5e-4,4,Proben4_500u_exp220322_run200522_40,NA
exp220322,exp220322.tsv,Ion transport,Gap junction,K+ channel (KvQT1/minK) antagonist,Connexin inhibitor,Mefloquine,Mefloq,TRUE,2022-03-22,2022-05-20,9,9d,10 uM,010u,9.999999999999999e-6,4,Mefloq1_010u_exp220322_run200522_41,NA
exp220322,exp220322.tsv,Ion transport,Gap junction,K+ channel (KvQT1/minK) antagonist,Connexin inhibitor,Mefloquine,Mefloq,TRUE,2022-03-22,2022-05-20,9,9d,10 uM,010u,9.999999999999999e-6,4,Mefloq2_010u_exp220322_run200522_42,NA
exp220322,exp220322.tsv,Ion transport,Gap junction,K+ channel (KvQT1/minK) antagonist,Connexin inhibitor,Mefloquine,Mefloq,TRUE,2022-03-22,2022-05-20,9,9d,10 uM,010u,9.999999999999999e-6,4,Mefloq3_010u_exp220322_run200522_43,NA
exp220322,exp220322.tsv,Ion transport,Gap junction,K+ channel (KvQT1/minK) antagonist,Connexin inhibitor,Mefloquine,Mefloq,TRUE,2022-03-22,2022-05-20,9,9d,10 uM,010u,9.999999999999999e-6,4,Mefloq4_010u_exp220322_run200522_44,NA
exp220322,exp220322.tsv,RTK,Src inhibitor,Src inhibitor,Connexin inhibitor,Saracatinib,Saraca,TRUE,2022-03-22,2022-05-20,9,9d,500 nM,500n,5.000000000000001e-7,4,Saraca1_500n_exp220322_run200522_05,NA
exp220322,exp220322.tsv,RTK,Src inhibitor,Src inhibitor,Connexin inhibitor,Saracatinib,Saraca,TRUE,2022-03-22,2022-05-20,9,9d,500 nM,500n,5.000000000000001e-7,4,Saraca2_500n_exp220322_run200522_06,NA
exp220322,exp220322.tsv,RTK,Src inhibitor,Src inhibitor,Connexin inhibitor,Saracatinib,Saraca,TRUE,2022-03-22,2022-05-20,9,9d,500 nM,500n,5.000000000000001e-7,4,Saraca3_500n_exp220322_run200522_07,NA
exp220322,exp220322.tsv,RTK,Src inhibitor,Src inhibitor,Connexin inhibitor,Saracatinib,Saraca,TRUE,2022-03-22,2022-05-20,9,9d,500 nM,500n,5.000000000000001e-7,4,Saraca4_500n_exp220322_run200522_08,NA
exp220322,exp220322.tsv,Aurora kinases,Aurora A kinase,Aurora A kinase inhibitor,Connexin inhibitor,Alisertib,Aliser,TRUE,2022-03-22,2022-05-20,9,9d,50 nM,050n,5.0000000000000004e-8,4,Aliser1_050n_exp220322_run200522_01,NA
exp220322,exp220322.tsv,Aurora kinases,Aurora A kinase,Aurora A kinase inhibitor,Connexin inhibitor,Alisertib,Aliser,TRUE,2022-03-22,2022-05-20,9,9d,50 nM,050n,5.0000000000000004e-8,4,Aliser2_050n_exp220322_run200522_02,NA
exp220322,exp220322.tsv,Aurora kinases,Aurora A kinase,Aurora A kinase inhibitor,Connexin inhibitor,Alisertib,Aliser,TRUE,2022-03-22,2022-05-20,9,9d,50 nM,050n,5.0000000000000004e-8,4,Aliser3_050n_exp220322_run200522_03,NA
exp220322,exp220322.tsv,Aurora kinases,Aurora A kinase,Aurora A kinase inhibitor,Connexin inhibitor,Alisertib,Aliser,TRUE,2022-03-22,2022-05-20,9,9d,50 nM,050n,5.0000000000000004e-8,4,Aliser4_050n_exp220322_run200522_04,NA
exp220322,exp220322.tsv,RTK,IGF-1R,IGFR and IR inhibitor,Connexin inhibitor,BMS-536924,BMS536,TRUE,2022-03-22,2022-05-20,9,9d,2 uM,002u,2e-6,4,BMS5361_002u_exp220322_run200522_13,NA
exp220322,exp220322.tsv,RTK,IGF-1R,IGFR and IR inhibitor,Connexin inhibitor,BMS-536924,BMS536,TRUE,2022-03-22,2022-05-20,9,9d,2 uM,002u,2e-6,4,BMS5362_002u_exp220322_run200522_14,NA
exp220322,exp220322.tsv,RTK,IGF-1R,IGFR and IR inhibitor,Connexin inhibitor,BMS-536924,BMS536,TRUE,2022-03-22,2022-05-20,9,9d,2 uM,002u,2e-6,4,BMS5363_002u_exp220322_run200522_15,NA
exp220322,exp220322.tsv,RTK,IGF-1R,IGFR and IR inhibitor,Connexin inhibitor,BMS-536924,BMS536,TRUE,2022-03-22,2022-05-20,9,9d,2 uM,002u,2e-6,4,BMS5364_002u_exp220322_run200522_16,NA
exp220322,exp220322.tsv,NF-kappaB,NF-κB,Inhibits NF-kappaB nuclear translocation,Connexin inhibitor,JSH-23,JSH23,TRUE,2022-03-22,2022-05-20,9,9d,60 uM,060u,5.9999999999999995e-5,4,JSH231_060u_exp220322_run200522_17,NA
exp220322,exp220322.tsv,NF-kappaB,NF-κB,Inhibits NF-kappaB nuclear translocation,Connexin inhibitor,JSH-23,JSH23,TRUE,2022-03-22,2022-05-20,9,9d,60 uM,060u,5.9999999999999995e-5,4,JSH232_060u_exp220322_run200522_18,NA
exp220322,exp220322.tsv,NF-kappaB,NF-κB,Inhibits NF-kappaB nuclear translocation,Connexin inhibitor,JSH-23,JSH23,TRUE,2022-03-22,2022-05-20,9,9d,60 uM,060u,5.9999999999999995e-5,4,JSH233_060u_exp220322_run200522_19,NA
exp220322,exp220322.tsv,NF-kappaB,NF-κB,Inhibits NF-kappaB nuclear translocation,Connexin inhibitor,JSH-23,JSH23,TRUE,2022-03-22,2022-05-20,9,9d,60 uM,060u,5.9999999999999995e-5,4,JSH234_060u_exp220322_run200522_20,NA
exp220322,exp220322.tsv,PI3K/AKT/mTOR - Autophagy,mTOR,mTOR inhibitor,Connexin inhibitor,Temsirolimus,Temsir,TRUE,2022-03-22,2022-05-20,9,9d,6 uM,006u,6e-6,4,Temsir1_006u_exp220322_run200522_25,NA
exp220322,exp220322.tsv,PI3K/AKT/mTOR - Autophagy,mTOR,mTOR inhibitor,Connexin inhibitor,Temsirolimus,Temsir,TRUE,2022-03-22,2022-05-20,9,9d,6 uM,006u,6e-6,4,Temsir2_006u_exp220322_run200522_26,NA
exp220322,exp220322.tsv,PI3K/AKT/mTOR - Autophagy,mTOR,mTOR inhibitor,Connexin inhibitor,Temsirolimus,Temsir,TRUE,2022-03-22,2022-05-20,9,9d,6 uM,006u,6e-6,4,Temsir3_006u_exp220322_run200522_27,NA
exp220322,exp220322.tsv,PI3K/AKT/mTOR - Autophagy,mTOR,mTOR inhibitor,Connexin inhibitor,Temsirolimus,Temsir,TRUE,2022-03-22,2022-05-20,9,9d,6 uM,006u,6e-6,4,Temsir4_006u_exp220322_run200522_28,NA
exp220322,exp220322.tsv,PI3K/AKT/mTOR,PI3K,PI3K inhibitor,Connexin inhibitor,AZD8186,AZD818,TRUE,2022-03-22,2022-05-20,9,9d,50 uM,050u,4.9999999999999996e-5,4,AZD8181_050u_exp220322_run200522_21,NA
exp220322,exp220322.tsv,PI3K/AKT/mTOR,PI3K,PI3K inhibitor,Connexin inhibitor,AZD8186,AZD818,TRUE,2022-03-22,2022-05-20,9,9d,50 uM,050u,4.9999999999999996e-5,4,AZD8182_050u_exp220322_run200522_22,NA
exp220322,exp220322.tsv,PI3K/AKT/mTOR,PI3K,PI3K inhibitor,Connexin inhibitor,AZD8186,AZD818,TRUE,2022-03-22,2022-05-20,9,9d,50 uM,050u,4.9999999999999996e-5,4,AZD8183_050u_exp220322_run200522_23,NA
exp220322,exp220322.tsv,PI3K/AKT/mTOR,PI3K,PI3K inhibitor,Connexin inhibitor,AZD8186,AZD818,TRUE,2022-03-22,2022-05-20,9,9d,50 uM,050u,4.9999999999999996e-5,4,AZD8184_050u_exp220322_run200522_24,NA
exp220322,exp220322.tsv,Oxidative stress,Mitochondrial biogenesis,inhibits  mitochondrial respiration,Connexin inhibitor,Levofloxacin,Levofl,TRUE,2022-03-22,2022-05-20,9,9d,250 uM,250u,2.5e-4,4,Levofl1_250u_exp220322_run200522_33,NA
exp220322,exp220322.tsv,Oxidative stress,Mitochondrial biogenesis,inhibits  mitochondrial respiration,Connexin inhibitor,Levofloxacin,Levofl,TRUE,2022-03-22,2022-05-20,9,9d,250 uM,250u,2.5e-4,4,Levofl2_250u_exp220322_run200522_34,NA
exp220322,exp220322.tsv,Oxidative stress,Mitochondrial biogenesis,inhibits  mitochondrial respiration,Connexin inhibitor,Levofloxacin,Levofl,TRUE,2022-03-22,2022-05-20,9,9d,250 uM,250u,2.5e-4,4,Levofl3_250u_exp220322_run200522_35,NA
exp220322,exp220322.tsv,Oxidative stress,Mitochondrial biogenesis,inhibits  mitochondrial respiration,Connexin inhibitor,Levofloxacin,Levofl,TRUE,2022-03-22,2022-05-20,9,9d,250 uM,250u,2.5e-4,4,Levofl4_250u_exp220322_run200522_36,NA
